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The cloning of novel Gonadotropin-releasing hormone receptors by PCR 
Gonadotropin-releasing hormone (GnRH), a central regulator of reproductive function in all 
vertebrates, exerts its effects via binding to the GnRH receptor (GnRHR) in the pituitary 
gonadotrophs. The GnRHR is a member of the G-protein coupled receptor (GPCR) 
superfarnily. A second form of the GnRHR (type II), other than the pituitary gonadotrope 
GnRHR (type I) has been proposed to exist and to play a role other than the classical 
endocrine role of the pituitary GnRHR. Elucidation of amino acid residues of the GnRHR that 
are crucial for ligand binding, activation of the receptor, and coupling to the G-protein, is 
important in understanding structure-function relationships towards the design of drugs for 
therapeutic intervention. Such information can often be deduced by a comparison between 
conserved and non-conserved amino acid residues of GnRHRs from different species. 
At the start of this project no non-mammalian or invertebrate, and only some of the eutherian 
mammalian type I GnRHRs had been cloned. The aim of this project was to clone novel 
GnRHRs, i.e. type I and type II GnRHRs from redbait and mole and type II mouse and 
human GnRHRs using polymerase chain reaction (PCR) strategies. PCR was performed with 
degenerate primers designed to human type I GnRHR to areas that are not conserved between 
GPCRs in general, but are conserved between mammalian GnRHRs. 
No positive results were obtained with any of the primer pairs tried on redbait. The reason 
this strategy did not work on redbait, might be that the redbait GnRHR differs much from that 
of the mammalian GnRH receptors. Another possibility is that there is no GnRHR in redbait. 
However, this is very unlikely, since GnRH has been detected in tunicates. 
A fragment of a novel type I mole GnRHR was obtained, corresponding to exon 1 of the 
human type I GnRHR. Exon 1 of type I mole GnRHR 89.5% is homologous to human type 
I GnRHR on the DNA level, and 93% on the amino acid level, and differed from the human 
type I GnRHR in only 4 amino acids out of a total of 96. These were all conservative changes 
that occurred in the transmembrane domains. This result was rather surprising given the 
lll 
evolutionary distance between the mole, a member of the non-placental eutherians, and 
humans, but showed that a strict requirement exists for conserved amino acids in the type I 
GnRHR for widely divergent mammals. Attempts to clone the putative type II GnRHR from 
mole or mouse were unsuccessful. 
Human genome data base searches revealed the presence of putative human type II GnRHR 
DNA sequences, indicating that a gene for a type II GnRHR exists in the human genome. 
Using gene specific primers designed to this sequence, it was shown that several human 
tissues and cell lines expressed a type II GnRHR RNA. In most tissues this mRNA contained 
an intron. An intron-less novel type II human GnRHR cDNA was cloned from human testes 
RNA, and corresponded to exons 2 and 3, minus intron 1, of the type I human GnRHR. The 
deduced amino acid sequence is 68% homologous to type I human GnRHR. An interesting 
feature of the type II GnRHR, is the presence of a C-terminal tail which is absent from all 
the type I mammalian GnRHRs cloned to date. This result shows that a processed RNA 
transcript (i.e. not containing the equivalent intron 2) coding for part of a type II GnRHR i.e. 
putative exons 2 and 3, is indeed expressed in at least one human tissue. This processed 
transcript is clearly of much lower abundance than the intron-containing transcript. Using a 
primer designed to span the exon 2/exon 3 boundary to selectively amplify processed RNA 
rather than intron-containing RNA, it was shown that several other human tissues may also 
express the processed type II GnRHR RNA. Human genomic DNA clones containing 
putative exons 2 and 3 of the type II GnRHR were purchased commercially. Analysis of 
these clones confirmed the existence of putative type II GnRHR exons 2 and 3 sequences in 
the human genome. The presence of type II GnRHR sequences corresponding to exon I of 
the type I GnRHR could not be detected in either human cDNAs from several tissues or in 
the human genomic clones. The inability to detect the presence of "full length" type II 
GnRHR transcripts may mean that they do not occur, or that we were unable to detect them 
due to their low abundance, or that they are not expressed in the tissues examined. From the 
results it was not possible to determine whether the processed transcript is the sense or the 
antisense strand. It is possible that the transcripts that were detected are antisense transcripts 
which could have a regulatory function in supressing transcription of the sense transcript. It 
remains to be shown whether the type II human GnRHR RNA expressed in testes and 
possibly in other tissues, and corresponding to exons 2 and 3 of the type I GnRHR, is 
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Gonadotropin releasing hormone (GnRH) is a hypothalamic decapeptide that is the key neural 
regulator of the reproductive process. It is synthesized by hypothalamic neurons, secreted in 
a pulsatile manner, and carried to the anterior lobe of the pituitary gland where it binds to 
receptors in the pituitary gonadotrophes. There, GnRH stimulates the secretion of luteinizing 
hormone (LH) and follicle stimulating hormone (FSH), which, in turn, regulate the 
gametogenic and hormonal functions of the gonads. 
The GnRH receptor (GnRHR) is a member of the G protein-coupled receptor (GPCR) family 
(Spiegel, 1989). They are a variety of cell-surface receptors that mediate their intracellular 
actions by a pathway that involves activation of one or more guanine nucleotide-binding 
regulatory proteins (G proteins) (Strader et al. , 1994). These receptors form a large and 
functionally diverse superfamily. Receptors that belong to this class respond to a variety of 
hormone and neurotransmitter agonists. The signalling pathway of this family normally 
involves the binding of the agonist to its receptor, causing conformational changes in the 
receptor (Strader et al., 1994). These changes allow the receptor to interact with the G 
protein to form an agonist-receptor-G protein complex. A wide variety of second-messenger 
molecules are influenced by the stimulation of G protein-coupled receptors with specific 
hormone agonists, including adenylyl cyclase, guanylyl cyclase, phospholipases C (PLC) and 
A2, and Ca2+ and K+ channels. Both the COOH- and NH2-termini of GnRH interact with the 
receptor, resulting in high affinity binding (King and Millar, 1995). The NH2-terminal 
sequence is essential for activating the receptors to allow initiation of the transducing signals 
(King and Millar, 1995). The GnRHR activates PLC through a G protein, which gives rise 
to the generation of inositol triphosphate (IP3) , which in turn mobilizes intracellular Ca
2+. 
PLC activation by GnRH also results in the generation of diacylglycerol (DAG) and 
consequent activation of protein kinase C (PKC). 
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Figure 1 Taxonomic distribution of GnRHs in vertebrates (King and Millar, 1995). CII, 
chicken GnRH II; M, mammalian GnRH; S, salmon GnRH; CI, chicken GnRH I; Cf, catfish 
GnRH; Df, dogfish GnRH; LI, lamprey GnRH I; LIII, lamprey GnRH III; U, an unidentified 
form of GnRH. Where identification of known GnRHs was not conclusive, the GnRH has 
been designated as an unidentified form of GnRH. 
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Figure 1 (Continued). Taxonomic distribution of GnRHs in vertebrates. (King and Millar, 
1995). CII, chicken GnRH II; M, mammalian GnRH; S, salmon GnRH; CI, chicken GnRH 
I; Cf, catfish GnRH; Df, dogfish GnRH; LI, lamprey GnRH I; LIII, lamprey GnRH III; U, 
an unidentified form of GnRH. Where identification of known GnRHs was not conclusive, 
the GnRH has been designated as an unidentified form of GnRH. 
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Figure 1 (Continued). Taxonomic distribution of GnRHs in vertebrates. (King and Millar, 
1995). CII, chicken GnRH II; M, mammalian GnRH; S, salmon GnRH; CI, chicken GnRH 
I; Cf, catfish GnRH; Df, dogfish GnRH; LI, lamprey GnRH I; LIII, lamprey GnRH III; U, 
an unidentified form of GnRH. Where identification of known GnRHs was not conclusive, 
the GnRH has been designated as an unidentified form of GnRH. 
Structural variants of GnRH 
Two or more molecular forms of GnRH, of which chicken GnRHII ( cGnRHII) ( first isolated 
from chicken by Miyamoto et al., 1984) is the most universally present form (Figure 1 ), are 
present in the brains of species from all the major non-mammalian vertebrate groups. This 
implies that there was a gene duplication in the earliest vertebrates and that cGnRHII has been 
highly conserved during vertebrate evolution (Millar and King, 1994; King and Millar, 1992, 
1995). Until recently only the mammalian form of GnRH (mGnRH) had been isolated in 
placental mammals. An interesting observation is that two forms are present in metatherian 
species (such as possum, Trichosurus vulpecula) and early-evolved eutherian species (musk 
shrew, Suncus murimus, and mole, Chrysochloris asiatica). Recently cGnRHII has been 
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reported to exist in primate brains (Lescheid et al., 1996). 
The data suggest that the primary role of the cGnRHII is not as a gonadotropin-releasing 
factor. Instead, the peptide probably acts as a neurotransmitter in the medial habenula and 
in other regions (Rissman et al. , 1995). 
The different GnRH variants are highly conserved in length and in the NH2- and COOH-
terminal sequences (Figure 2) (Millar and King, 1994). Position 8 is the most variable, 
followed by positions 5, 7, and 6. The existence of at least two different types of GnRH in 
most vertebrates (Millar and King, 1994) suggests the possibility of different GnRH receptor 
subtypes. 
1 2 3 4 5 6 7 8 9 10 
MAMMAL pGlu Hi Tr Se Tyr Gly Leu Arg Pro Gl y NH2 
CHICKEN I pGlu Hi Tr Se Tyr Gly Leu Gln Pro Gly NH2 
SEA BREAM pGlu Hi Tr Se Tyr Gly Leu Ser Pro Gly NH2 
CATFISH pGlu Hi Tr Se His Gly Leu Asn Pro Gly NH2 
SALMON pGlu Hi Tr Se Tyr Gly Trp Leu Pro Gly NH2 
DOGFISH pGlu Hi Tr Se His Gl y Trp Leu Pro Gly NH2 
CHICKEN II pGlu Hi Tr Se His Gly Trp Tyr Pro Gly NH2 
LAMPREY II pGlu Hi Tr Se His Asp Trp Lys Pro Gly NH2 
LAMPREY I pGlu Hi Ty Se Leu Glu Trp Lys Pro Gly NH2 
TUNICATE I pGlu Hi Tr Se Asp Tyr Phe Lys Pro Gly NH2 
TUNICATE II pGlu Hi Tr Se Leu Cys His Ala Pro Gly NH2 
Figure 2 Primary structure of the eleven GnRHs isolated from vertebrate brain. Boxes show 
highly conserved residues (King and Millar, 1995; Sherwood, 1995). 
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Function of GnRH 
The role of GnRH in stimulating gonadotropin release has been established in various 
vertebrate species. However, it has become evident that GnRH has additional functions. 
GnRH has been shown to affect the secretion of other pituitary hormones such as growth 
hormone in some fish species, as well as the activity of cells of a number of non-pituitary 
tissues (Millar and King, 1994). The existence of eleven structural variants of GnRH, 
together with the occurrence of more than one form of GnRH in most species, i.e. cGnRHII 
and a second form which varies in the different species (mGnRH in mammals), could be 
indicative of diversity in functional regulation by GnRHs (Millar and King, 1994). 
In the musk shrew brain the distribution of cGnRHII is very different from the distribution 
of mGnRH fibres and cells (Rissman et al., 1995). Also, there is no overlap in the 
distribution of neurons that contain mGnRH and cGnRHII (Dellovade et al., 1993)(Figure 3). 
In addition, there is also little overlap in the projection sites of these neurons. The majority 
of the forebrain neurons that produce mGnRH project along a midline ventral path from the 
olfactory regions toward the median eminence (Silverman, 1988; Dellovade et al., 1993). 
In contrast, the major projection site of the cGnRHII cells is the medial habenula. Taken 
together, the data strongly suggest that the primary role of the cGnRHII form of GnRH is not 
as a gonadotropin-releasing factor, but instead, the peptide probably acts as a neurotransmitter 
in the medial habenula and in other regions. 
The GnRH subtype dominant in the hypothalamus (mGnRH for mammals) seems to serve a 
role in regulating pituitary gonadotropins. This GnRH subtype varies in different species. The 
conserved cGnRH II subtype, more prevalent in extrahypothalamic brain areas and probably 
peripheral nervous system, may serve as a neurotransmitter or neuromodulator within the 
nervous system (Millar and King, 1994; King and Millar, 1995). This opinion is based on 
several findings: (i) GnRH is distributed throughout the brain (Mikami et al., 1988; Katz et 
al., 1990; Sharp et al., 1990); (ii) GnRH receptors are present in several brain areas; (iii) 
GnRH has direct effects on reproductive behaviour; and (iv) GnRH affects the function of 
amphibian sympathetic ganglion neurons. 
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Outside the central nervous system, cGnRHII has paracrine effects in the gonads, where it 
affects steroid hormone production, and in the placenta, where it simulates secretion of 
chorionic gonadotropin (Hsueh and Schaeffer, 1985). In breast tumor cells GnRH seems to,. 
have an autocrine regulatory role. The GnRH gene is expressed here (Harris et al., 1991 ), 
GnRH receptors are present (Barron et al., 1985), and GnRH antagonists inhibit cell growth 
(Eidne et al., 1987). 
In different tissues, specificity of action of GnRH is thought to be achieved through 
anatomical arrangements that ensure exclusive delivery of effective concentrations to the target 
cells. Hypothalamic GnRH is transported to the anterior pituitary via portal vessels. In 
mammals, the concentrations of this GnRH is too low in general circulation to allow bjnding 
to GnRHR.s in other tissues (Millar and King, 1994). Gonadal and placental GnRHs are 
thought to be secreted by specific cells to affect adjacent cells in a paracrine fashion, and the 
same exclusive communication is retained when the hormones function as neurotransmitters 
or as autocrine regulators (Millar and King, 1994). 
• mammalian GnRH cell populations 
• chicken II GnRH cell populations 
Figure 3 Schematic drawing of a parasagittal musk shrew brain. Each dot 
represents at least five GnRH-irnrnunoreactive neurons that contain mGnRH, 
and each ttjangle represents at least five cGnRH-II-ir neurons. AOB, 
accessory olfactory bulb; :ME, median eminence; NT, nervus terrninalis; OB, 
olfactory bulb; POA, preoptic area; TT, tenia tecta; ac, anterior cornrnissure; 
Aq, aqueduct; gee, genu corpus callostim; mlf, medial · longitudinal 
fasciculuc; ox, optic chiasm; 3V, third ventricle (Rissman. et al., 1995). 
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Receptor structure 
The GnRHR is a cell-surface receptor, sharing the typical structural formation of the G-protein 
coupled receptors. The receptor is characterized by seven hydrophobic stretches of 20-25 
amino acids, predicted to form transmembrane a-helices, connected by alternating extracellular 
and intracellular loops (Figure 4). Most of the primary sequence homology among this family 
of receptors is contained within the hydrophobic transmembrane domains, with the hydrophilic 
loop regions being more divergent (Strader et al., 1994; Millar et al., 1993). 
The % homology between the transmembrane domains of 2 different G protein-coupled 
receptors at amino acid level, can be a good indication of the relationship between the 2 
receptors (Strader et al., 1994). A 85-95% identity indicates species homologues, whereas 
60-80% is indicative of related subtypes of the same receptor. Other members of the same 
family are 35-45% identical, whereas unrelated G protein-coupled receptors are 20-25% 
identical. 
G protein-coupled receptors are glycoproteins. All GPCRs cloned to date, have one or more 
consensus sequences for N-linked glycosylation (Asn-X-Ser/Thr) in the extracellular domain. 
These sites are usually located near the N terminus of the protein, although putative 
glycosylation sites have also been found in the second extracellular loop (Strader et al., 1994). 
A number of cysteine residues have been conserved in G protein-coupled receptors, some of 
which appear to play a role in the receptor structure (Strader et al. , 1994). The high degree 
of structural similarity of the family of G protein-coupled receptors is indicative of the 
common mechanism of action of these different receptors (Strader et al., 1994). 
The most notable difference of the GnRH receptor compared to other G protein-coupled 
receptors, is the absence of an intracellular C-terminal tail (Millar et al. , 1993; Stojilkovic et 
al., 1994). Other unique features include the lack of a conserved aspartate/glutamate in the 
second transmembrane (TM2) domain (GnRH receptor has an asparagine), the length and 
highly basic nature of the first cytoplasmic loop, and the short overall length of the receptor 
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Figure 4 Proposed structure of the human pituitary (Type I) GnRH receptor. The shaded 
areas indicate amino acids that are conserved within the G protein-coupled receptor 
superfamily. 
protein. (Millar et al. , 1993). Another difference between the GnRH receptor and other G 
protein-coupled receptors, is the change of the highly conserved DRY sequence to DRS at the 
TM2 I intracellular loop 2 junction (Millar et al., 1993). 
Most of the GPCRs are buried in the membrane, exposmg only a small surface to the 
cytoplasm. This surface is composed predominantly of the ends of the transmembrane helices 
and the connecting loops. Much of this intracellular surface is thought to be involved in the 
interaction with G proteins. Studies have implicated residues at the cytoplasmic ends of all 
helices and the portions of the loops closest to the membrane as critical for overall interaction 
and specificity determination. Other lines of evidence point to the importance of the 
intracellular loops in activating the G proteins (Strader et al. , 1994). 
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Distribution of GnRH receptors 
GnRH receptors have been characterized as specific binding sites with high affinity for GnRH 
and its potent agonist or antagonist analogs in the pituitaries of several species, including rat 
(Naor et al., 1980), human (W ormald et al., 1985), mouse (Pal et al. , 1992), rabbit (Limonta 
et al., 1986), goldfish (Peter et al., 1992), and the African catfish, Clarias gariepinus (Schulz 
et al. , 1993). The presence of GnRH receptors have also been confirmed using radiolabelled 
GnRH analogues by autoradiography in the brain, specifically the hippocampus, lateral septal 
nucleus, anterior angulate cortex, subiculum, and entophinal cortex. GnRH receptor 
expression has also been detected in the testis (Clayton et al., 1980; Bourne et al., 1980), 
ovary (Clayton et al., 1979; Hazum and Nimrod, 1982; Pati and Habibi, 1992), the human 
placenta, human breast tumor (Eidne et al., 1985; Eidne et al., 1987), human epithelial 
ovarian carcinomas (Pahwa et al., 1989; Emons et al., 1992), as well as in prostate tumors 
(Qayum et al., 1990). The existence of GnRH and GnRHR mRNA's in normal non-
reproductive tissues suggests that in addition to regulating the secretion of gonadotropins from 
the anterior pituitary, GnRH and GnRHR may play an important role in the regulation of 
cellular functions in an autocrine or paracrine manner. 
Cloning of GnRH receptor cDNAs 
The GnRHR was first cloned in mouse by Tsutsumi et al. in 1992. The authors isolated a 
GnRHR cDNA from the gonadotrope cell line , aT3-1, using a PCR-based strategy. aT3-1 
RNA was used as a template for the synthesis of cDNA with degenerate oligo's designed to 
conserved regions of the GPCRs. PCR products were subcloned and sequenced, whereupon 
antisense oligo's were synthesized for a hybrid-arrest assay. Two oligo ' s were found to 
completely abolish the expression of GnRHR in oocytes when coinjected with aT3-1 and rat 
brain RNA. These two oligo's represented different segments of a specific clone (WZ7). 
Clone WZ7 was then used as a probe to screen an aT3-1 cDNA library. Seven positive 
plaques were detected, of which the largest insert was 1.3 kb (clone WZ25). To check if 
WZ25 encoded a functional GnRHR, it was subcloned, and injected into oocytes. These 
oocytes, when exposed to GnRH, demonstrated a large depolarizing response characteristic 
of GnRHR expression. The pharmacology of the response obtained was in agreement with 
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expression of the mammalian GnRHR. 
Following the cloning of the first GnRHR, the GnRHR has been cloned in a variety of 
placental mammalian species, including human (Chi et al., 1993; Kakar et al. , 1992), mouse 
(Reinhart et al. , 1992), rat (Eidne et al., 1992; Kaiser et al., 1992), cattle (Kakar et al., 
1993), pig (Weesner and Matteri, 1994) and sheep (Brooks et al. , 1993; Illing et al., 1993). 
The analysis of the different GnRH receptors revealed that the GnRHR is highly conserved 
between different mammalian species (Figure 5). cDNA library screening was used for the 
























101 Continued on next page 
Figure 5 Comparison of the amino acid sequences of the sheep, human, mouse, and 
rat GnRHR. Amino acids are shown in one-letter code. Amino acids that are not 
conserved between different species are printed in bold. Transmembrane (TM) helices 





















101 ECl TM3 IC2 151 
WNITVQWYAGELLCK VLSYLKLFSMYAPAFMMVVISL DRSLAITRPLAVK 
WNITVQWYAGELLCK VLSYLKLFSMYAPAFMMVVISL DRSLAITRPLAIK 
WNITWQWYAGEFLCK VLSYLKLFSMYAPAFMMVVISL DRALAITQPLAVQ 
WNITVQWYAGEFLCK VLSYLKLFSMYAPAFMMVVISL DRSLAVTQPLAVQ 
151 TM4 EC2 200 
SNSKLGQF MIGLAWLLSSIFAGPQLYIFGMI HLADDSGQTEGFSQCVTHCS 
SNSKVGQS MVGLAWILSSVFAGPQLYIFRMI HLADSSGQTKVFSQCVTHCS 
SNSKLEQS MISLAWILSIVFAGPQLYIFRMI YLADGSGPI-VFSQCVTHCS 
SKSKLERS MTSLAWILSIVFAGPQLYIFRMI YLVDGSGPA-VFSQCVTHCS 
201 TM5 250 
FPQWWHQAFYN FFTFSCLFIIPLLIMLICNAKIIF TLTRVLHQDPHKLQL 
FSQWWHQAFYN FFTFSCLFIIPLFIMLICNAKIIF TLTRVLHQDPHELQL 
FPQWWHQAFYN FFTFGCLFIIPLLIMLICNAKIIF ALTRVLHQDPRKLQM 
FPQWWHEAFYN FFTFSCLFIIPLLIMLICNAKIIF ALTRVLHQDPRKLQL 






DPVNH FFFLFGFLNPCFDPLIYGYF SL 
DPVNH FFFLFAFLNPCFDPLIYGYF SL 
EPVNH FFFLFAFLNPCFDPLIYGYF SL 






Figure 5 ( continued) Comparison of the amino acid sequences of the sheep, 
human, mouse, and rat GnRHR. Amino acids are shown in one-letter code. Amino 
acids that are not conserved between different species are printed in bold. 
Transmembrane (TM) helices indicated with boxes. 
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Gene structure of the GnRHR 
The type I human GnRHR gene consists of at least three exons and 2 introns and spans over 
18.9 kb (Fan et al., 1994)(Figure 4). Exon 1 consists of the 5' -untranslated region (5'UTR) 
and part of the open reading frame (ORF) encompassing transmembrane (TM) domains 1 to 
3, and a portion of TM4. Exon 2 is only 219 bp in size, and codes for the remainder of 
TM4, as well as for TM5. Exon 3 encodes the COOR-terminal part of the ORF (TM6 + 
TM7) and the 3 'UTR. The presence of 2 introns within the protein coding region is quite 






TMI II III IV V 
I._J 
!kb 
3' gene structure 
t-----'3' cDNA 
VI VII 
Figure 6 Schematic representation of the human GnRHR gene (Fan et al., 1994). (A) 
Exon-intron localization (B) The structure of human GnRHR cDNA. Open box 
indicates the protein coding regions and hatched boxes are the putative transmembrane 
domains. 
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Aim of study 
The aim of this study was to attempt to clone novel GnRH receptors from redbait and mole 
using a PCR strategy. Two or more molecular forms of GnRH had been identified in the 
brains of most of the non-mammalian vertebrate groups, but until recently, only the 
mammalian form of GnRH (mGnRH) had been isolated in placental mammals. The existence 
of more than one molecular form of GnRH in a single species led us to believe that more than 
one form of the GnRHR was probably also present. The early-evolved eutherian species are 
the most highly evolved mammals for which good evidence exists for the presence of 
cGnRHII (Figure 1 ). The mole, a species readily available in our region, is a member of the 
early-evolved eutherians and as such is a good candidate to use to search for the presence of 
a novel mammalian GnRHR for cGnRHII that might differ substantially from the type I 
mammalian GnRHRs characterized to date. Another aim of this study was to find a type II 
GnRHR in higher mammals. 
Recent evidence shows that the primitive tunicate, Chelyosoma productum (sea squirt), 
contains GnRH (Powell et al. , 1996). The cloning of a GnRHR from such primitive tunicates 
would be very interesting since the species is evolutionary far separated from mammals, and 
one would expect that regions critical for receptor function would be selectively conserved 
whereas other regions may differ substantially from the mammalian GnRHRs. Redbait is a 
tunicate that is readily available in our region and is thus a good candidate for the search of 
novel GnRHRs from primitive tunicates. 
A series of degenerate oligonucleotide primers was designed (J.P. Hapgood) to the areas of 
the type I mammalian GnRHR that are not conserved between GPCRs in general, but are 
conserved within mammalian GnRHRs. PCR would thus hopefully amplify novel GnRH 
receptors and not any other GPCR. As far as possible, codons were chosen with the least 
degeneracy. This would make the PCR more specific, and thus lessen the chance of non-
specific amplifications. Also, primer pairs were chosen within an exon, given that successful 
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amplification of exons across large introns was unlikely. This strategy is based on the 
assumption that the gene structure of the GnRHR is conserved within the different mammalian 
species. 
Knowledge of the primary structure of the GnRHR from other mammals will allow us to 
identify important conserved and variant amino acids, and to correlate this with the difference 
in pharmacology of the receptors. The cloning of GnRHRs will allow rapid progress of our 
understanding of the molecular mechanisms of receptor regulation and the role these play in 
reproductive physiology. There have already been indications that GnRH plays an important 
role in reproductive behaviour in the musk shrew (Rissman et al., 1995). 
The reason for cloning novel GnRH receptors includes importance in development of 
therapeutic drugs. Residues that are conserved are likely to be important in receptor 
configuration, ligand induced molecular switching, and coupling to G-proteins. A variety of 
GnRH analogues have already successfully been used in the treatment of a variety of tumours 
and endocrine disorders. The more we know about the structure of GnRH receptors, the more 
impact this could have in the medical field. Knowledge of the GnRHR structure, its 
interaction with GnRH and GnRH analogues, and its physiological regulation is vital to our 
understanding of the functioning of the hypothalamic-pituitary-gonadal axis. 
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CHAPTER 2 
MATERIALS AND METHODS 
1. AGAROSE GEL ELECTROPHORESIS 
Agarose gel electrophoresis was performed according to the specifications described by 
Sambrook et al., 1989. 
Agarose was weighed and placed into an Erlenmeyer flask, to which the appropriate volume 
of Ix gel running buffer was added. Generally, agarose gels were run in lxTBE, except low 
melting point agarose gels which were run in lxT AE. The Erlenmeyer flask was sealed with 
clingwrap which was pierced to prevent the buildup of steam. The agarose mix was then 
heated in a microwave oven in the minimum time required to allow all of the grains of 
agarose to dissolve. The solution was cooled to 50°C, and ethidium bromide (EtBr, 10 
mg/ml) was added to a final concentration of 0.5 µg/rnl. The solution was swirled to allow 
the EtBr to mix, and then poured into the gel mold. Gels were generally between 5 mm and 
8 mm thick and were allowed to set at room temperature. Mini gels were 66x 100 mm, and 
midigels were 110x150 mm. 
Gels were run in just enough 1 x electrophoresis buffer to cover the gels to a depth of about 
1 mm. Gels were run at a voltage of 1 - 5 V/cm (measured as distance between electrodes). 
DNA on the gels was visualised by ultraviolet (UV) light. 
The necessary precautions outlined in Sambrook et al, 1989, was taken when working with 
EtBr or UV light. 
2. ISOLATION OF GENOMIC DNA 
Redbait (Pyura stolonifera) was collected at Kalkbaai with the assistance of W. Liebrich and 
J. Hapgood. The samples were put in a bucket with saltwater (seawater) immediately after 
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removal from the rocks. The redbait was dissected at the laboratory by E. Hutchinson, J. 
Hapgood, and W. Liebrich. Tissues were placed on dry ice immediately after dissection, and 
then stored at -70°C. 
Moles (Chrysochloris asiatica) were donated by Kirstenbosch Gardens. Mouse and mole 
dissections were performed by John Morta. Tissues were placed in liquid nitrogen 
immediately after dissection, and then stored at -70°C. 
Human genomic DNA was kindly donated by Genee Harmse. 
Preparation of genomic DNA (gDNA) was performed under RNase-free conditions. RNase-
free solutions and plugged tips were used throughout the procedure. 
As soon as possible after excision the tissue was frozen in liquid nitrogen. This is essential 
in order to minimize the activity of endogenous nucleases. Digestion buffer (100 mM NaCl; 
10 mM Tris.Cl (pH 8); 25 mM EDTA (pH 8); 0.5% sodium dodecyl sulfate (SDS); 0.1 
mg/ml proteinase K) was added (1.2 ml per 100 mg tissue). EDTA is included in the 
digestion buffer to inhibit DNases. The tissue was then ground in a homogeniser until no 
clumps remained. It is important that the tissue be well dispersed and not left in large clumps 
to permit rapid and efficient access to proteinase K and SDS. The samples were then 
incubated with shaking at 50°C for 12 to 18 hours in tightly capped tubes. After an overnight 
incubation the samples were thoroughly extracted with an equal volume of 
phenol/chloroform/isoamyl alcohol (PCI) (25 :24: 1 vol/vol) and centrifuged at 1700xg for 10 
minutes in a swinging bucket rotor. This procedure was repeated three times. The aqueous 
layer was then transferred to a new tube and Yi vol 7.5 M ammonium acetate and 2 vol 100% 
ethanol added. The DNA should immediately form a stringy precipitate. DNA was recovered 
by centrifugation at 1700xg for 2 minutes. The pellet was rinsed with 70% ethanol and air 
dried. DNA was resuspended in TE (10 mM Tris.HCl, 1 mM EDTA, pH 8.0) until dissolved. 
To remove residual RNA 0.1 % SDS and 1 µ.g/ml DNase-free RNase A was added. The DNA 
was then incubated at 37°C for 1 hour. This was followed by organic extraction and ethanol 
precipitation, as described above. The integrity of the genomic DNA was checked by agarose 
gel electrophoresis. No degradation of gDNA could be detected, as the gDNA all appeared 
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to be bigger than 20 kb when checked on an agarose gel. 
3. SOUTHERN HYBRIDIZATION 
The objective of a Southern transfer is to set up a flow of liquid from the reservoir through 
the gel and the nylon membrane, so that DNA fragments are eluted from the gel and are 
deposited onto the nylon membrane (Figure 7). 
paper towels 
nitrocellulose filter 
or nylon membrane 
Whatman 3MM paper 
weight 
.-----------, ~ -~glass plate 
SOOg ~ 
~ Whatman 3MM paper 
~~gel 
support 
Figure 7 Capillary transfer of DNA from agarose gels. Buffer is drawn from a reservoir and 
passed through the gel into a stack of paper towels. The DNA is eluted from the gel by the 
moving stream of buffer and is deposited on a nylon membrane. A weight applied to the top 
of the paper towels helps to ensure a tight connection between the layers of material used in 
the transfer system (Sambrook et al., 1989). 
3 .1 Preparation of the gel 
After electrophoresis was completed, gels were photographed. A ruler was placed alongside 
the gel so that the distance that any given band of DNA migrated could be read directly from 
the photographic image. The gel was then transferred to a glass dish and any unused areas 
of the gel were trimmed away with a razor blade. 
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3 .2 Gel denaturation 
The DNA was denatured by soaking the gel in 1.5 M NaCl and 0.5 M NaOH for 30 min at 
room temperature with constant shaking. This was followed by a short wash in distilled 
water. The gel was neutralized by soaking in several volumes of 1.5 M NaCl, 0.5 M Tris.Cl 
(pH 8.0) and 0.001 M EDTA (pH 8.0) for 15 min at room temperature with shaking. This 
was followed by a distilled water wash. The neutralization step was repeated for another 15 
min, followed by another water wash. 
3.3 Capillary Transfer 
A glass dish was filled with 20 x SSC (3M NaCl, 0.3 M Na3citrate). SSC acts as the transfer 
buffer. A glass plate was used as a platform. The support should be longer and wider than 
the gel. This was covered with 2 sheets of Whatman 3MM paper, saturated with transfer 
buffer (20xSSC). Air bubbles were smoothed out with a pipette. It is also important to 
ensure that the wick does not touch the sides of the glass dish. 
The gel was inverted so that its original underside was uppermost and placed on the damp 
3MM paper. Air bubbles between the gel and the 3MM paper were removed with a pipette. 
A piece of nylon membrane (Hybond N+, Amersham) cut to 1-2 mm bigger than the gel in 
both length and width and soaked in 2x SSC until wet, was placed on top of the gel. Bubbles 
between the gel and the membrane were removed. Three sheets of 3MM paper cut to the 
same size as the membrane and wetted in buffer was placed on top of the membrane. Air 
bubbles were removed again. This was all covered with clingwrap. A hole was cut in the 
clingwrap so that the gel was uncovered. The clingwrap prevents evaporation of the transfer 
buffer. A stack of absorbent paper towels (± 5-10 cm high), of similar size to that of the 
3MM paper, was then placed on top of the 3MM paper. A glass plate was placed on the 
paper towels. This was weighed down by a 500 - 750 g weight. Transfer was allowed to 
proceed overnight (16-24 hours). The rate of transfer of DNA depends on the size of the 
DNA fragment and the porosity of the gel. 
After the overnight transfer, the paper towels and the 3MM filters above the gel were 
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removed. The positions of wells and the edges of the gel were marked on the membrane with 
a soft pencil. The membrane was then rinsed briefly ( < 1 min) and carefully in 2 x SSC to 
remove any adhering agarose. DNA was fixed on the membrane by alkaline fixation. 
3.4 Alkaline fixation of DNA on membrane 
The DNA was fixed on the membrane according to the specifications of the manufacturers. 
The membrane was placed DNA side up on a pad of absorbent filter paper (Whatman 3MM), 
3 pieces thick, for 20 min at room temperature. The absorbent filter paper had been soaked 
in 0.4 M NaOH. The membrane was then rinsed in 5x SSC with gentle agitation for no more 
than 1 min. Excess fluid was allowed to drain from the membrane. The membrane was then 
dried at room temperature on 3MM paper. 
If the membrane was used immediately, it was placed in prewarmed prehybridization buffer 
immediately. Membranes not used immediately were vacuum sealed and stored at 4°C. 
3.5 Preparation of the human type I GnRHR probe 
The human type I GnRHR cDNA was cloned into Bluescript. Restriction enzyme digestions 
were performed with EcoRl and Xhol to cut out the insert of 1.2 kb (Section 4, Materials and 
Methods). The digestion mix was run on a low melting point agarose gel to separate the 1.2 
kb insert from the 3.0 kb vector. The insert was cut out with a sterile razor blade. The gel 
slice was stored in a 1.5 ml eppendorf tube at -20°C. Labelling of the human type I GnRHR 
probe was performed in gel. 
3.6 32P Labelling of Probe 
When working with 32P, all necessary precautions were taken, as outlined by Ausubel et al. , 
1987. Gloves and lab overcoats were worn at all times. Reactions were performed behind a 
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plexiglass screen. The equipment was checked with a Geiger counter regularly to monitor 
contamination. 
Three different techniques were used to label probes. 
3.6.1 [y-32P] d.ATP end-labelling of a single-stranded oligo with T4 polynucleotide kinase 
The following were combined in a 1.5 ml eppendorf tube: 100 pmoles of oligo; 4 µJ of 1 Ox 
PNK buffer; 5 µl of ['y-32P] d.ATP (50 µCi) and 5 µl of T4 PNK(400). The volume was 
adjusted to 40 µl with distilled water. The mixture was then incubated at 37°C for 45 min, 
followed by a 10 min incubation at 68°C. The mixture was then placed on ice. The volume 
was adjusted to 100 µl with STE (TE (pH 8.0) containing 0.1 M NaCl). Unincorporated ['Y-
32P] dATP and excess salt was removed by centrifugation through Sephadex G-50 packed in 
disposable syringes (Section 2.6.4, Materials and Methods). 
3.6.2 [a-32P] dCTP labelling of a double-stranded probe in agarose with Amersham' s 
Megaprime Kit 
Probes were labelled with [a-32P] dCTP (10 µCi/µl). The protocol recommended by the 
manufacturers was followed. 
The required components from the Megaprime kit (not the enzyme) were thawed at room 
temperature. To melt the gel slice containing the DNA, it was placed in boiling water in a 
1.5 ml tube for 30 sec. The required volume (25 ng DNA in a maximum of 21 µl) was added 
to a clean tube and 5 µl of primer was added. This mixture was incubated at 95°C for 5 min 
and then spun down. The following mixture was added at room temperature: 4 µl dATP, 
4 µl dGTP, 4 µl dTTP, 5 µl reaction buffer, 2 µl Klenow enzyme, and "x" µl of water to a 
final volume of 45 µl. This solution was mixed and spun down. Radioactive dNTP, 5 µl of 
[a-32P] dCTP (50 µCi) , was added carefully. The tube was incubated at 37°C for 10 min. 
The labelling reaction was stopped by the addition of 5 µl of 0.2 M EDT A. The labelled 
probe was purified on a G-50 Sephadex spin column (Section 2.6.4, Materials and Methods). 
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3.6.3 [a-32P] dCTP labelling of a probe by PCR 
The following mixture was added to a 0.5 ml tube: 2.5 µl 50 mM MgC12, 5 µl lOx PCR 
buffer (200 mM Tris-HCl (pH 8.4), 500 mM KCl), 4 µl dNTP ' s (dATP, dGTP, dTTP), 5 µl 
[a-32P] dCTP (50 µCi), 1 µl primer 1, 1 µl primer 2, "x" µl DNA, 0.5 µl Taq (5U/µl Taq 
DNA polymerase from Thermus aquaticus YTl, Gibco BRL), and "x" µl of water to a final 
volume of 50 µl. The mixture was covered with 50 µl of mineral oil. The PCR cycle used 
was as follows: 93°C for 10 min, followed by 35 cycles of 1 min at 93°C, 2 min at 55°C and 
3 min at 72°C. This was followed by a 10 min extension period at 72°C. The PCR mixture 
was separated from the oil on parafilm. Unincorporated [a-32P] dCTP and excess s~lt was 
removed by centrifugation through Sephadex G-50 packed in disposable syringes (Section 
2.6.4, Materials and Methods). 
3.6.4 Preparation of a G-50 Sephadex Spin Column 
Sephadex G-50 equilibrated in STE was prepared to a bed volume of 0.9 - 1.0 ml in a 1-ml 
disposable syringe plugged with a small amount of sterile glass wool. The syringe was placed 
into a disposable centrifuge tube and centrifuged at 400xg for 1 min, causing the Sephadex 
to pack down. The column was washed with 0.1 ml STE and recentrifuged at exactly the 
Figure 8 Schematic diagram of 
Sephadex G-50 spin column (Sambroo 
et al., 1989). Sephadex 
G-50 
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same speed and for exactly the same time as before. This was repeated three times. The 
DNA sample was then applied to the column in a volume of 0.1 ml. This was recentrifuged 
at exactly the same speed and for exactly the same time as before. The 100 µ.l effluent from 
the syringe was collected in a decapped eppendorf tube. The unincorporated [32P] dNTP's 
remain in the syringe, which should be carefully discarded. 
3. 7 Hybridization of Southern filters 
Three different hybridization conditions were used. The choice of hybridization solution 
depended on the probe used, as well as the stringency required. The stringency is dependant 
on the GC content of the probe, as well as the percent homology of the probe to the target. 
The hybridizations were performed in a closed flat-bottomed plastic container. ± 0.25 ml 
prehybridization/hybridization solution was used per cm2 membrane. The membranes were 
washed until no background "noise" remained. 
3.7.1 Hybridization conditions for ['.)'.-32P] dATP end-labelled oligo 
Prehybridization solution (6x SSC (3 M NaCl, 0.3 M sodium citrate); 0.4% SDS; 5x 
Denhardt's solution (0.1% (w/v) bovine serum albumin (BSA); 0.1% (w/v) Ficoll™, 0.1% 
(w/v) polyvinylpyrrolidone (PVP)); 20 mM NaH2P04 (pH 7.5); 0.5 mg/ml denatured herring 
sperm DNA) was prewarmed to 60°C in a waterbath in a flat-bottomed plastic container with 
lid. The filter was immersed in this solution and incubated at 60°C for 1 hour with shaking. 
The prehybridization solution was discarded, and prewarmed ( 60°C) hybridization solution 
(6x SSC; 20 mM NaH2P04 (pH 7.5); 0.4% SDS; 0.5 mg/ml denatured herring sperm DNA; 
[)'-
32P]-labelled probe DNA) was added. The filter was incubated at 60°C for 3 hours for 
hybridization. 
After the 3 hour hybridization period, the filter was removed and immediately submerged in 
a container containing a solution of 6x SSC and 0.1 % SDS prewarmed to 42°C. The filter 
was incubated at 42°C for 10 min with shaking. It is very important that the filter must not 
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be allowed to dry out at any stage during the washing procedure. After 10 minutes the filter 
was placed in a fresh solution of 6x SSC and 0.1 % SOS (prewarmed to 42°C) and incubated 
at 42°C for 10 min with shaking. This was repeated once more. 
This was followed by three 10 min washes at 60°C in a solution containing lx SSC and 0.1 % 
SOS. These washes were followed by three 10 min washes at 65°C in a solution containing 
O.lx SSC and 0.1% SOS. 
After the washes, the filter was briefly dried at room temperature on a sheet of 3MM 
Whatman. The filter was then sealed in clingwrap and exposed to pre-flashed X-ray film 
(Hyperfilm MP, Amersham) in a light-excluding cassette with intensifying screen to obtain 
an autoradiographic image. The cassette was placed at -70°C. 
3. 7 .2 Low stringency hybridization conditions 
Prehybridization solution (6x SSC; 5x Denharts; 0.5% SDS; and 100 µg/ml denatured herring 
sperm DNA) was prewarmed to 50°C in a waterbath in a flat-bottomed container. The filter 
was immersed in this solution and incubated at 50°C with shaking for at least 1 hour. 
After an hour the prehybridization solution was discarded and prewarmed (50°C) hybridization 
solution (6x SSC; 0.5% SDS; 100 µg/ml denatured herring sperm DNA; denatured probe) was 
added. The filter was incubated overnight at 50°C with shaking. 
All the washes were performed in a flat-bottomed plastic container with shaking. When 
hybridization was complete, the membrane was removed and immediately placed in a 
container with 2x SSC, 0.1 % SDS. After 20 min at room temperature, the solution was 
replaced with lxSSC, 0.1 % SOS, prewarmed to 50°C. After a further 20 min, this solution 
was replaced with 0.5x SSC, 0.1 % SDS, also prewarmed to 50°C. The membrane was 
washed in this solution for 20 min. 
After the washes, the filter was dried briefly at room temperature on a sheet of 3MM 
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Whatman. The filter was then sealed in clingwrap and exposed to pre-flashed X-ray film 
(Hyperfilm MP, Amersham) in a light-excluding cassette with intensifying screen to obtain 
an autoradiographic image. The cassette was placed at -70°C. 
3.7.3 High stringency hybridization conditions 
Prehybridization solution (2x PIPES (0.8 M NaCl, 0.02 M PIPES (Piperazine-N, N' -bis-[2-
ethanesulfonic acid]), pH 6.5); 50% deionized formamide; 0.5% SDS; 100 µg/ml denatured 
herring sperm DNA) was prewarmed to 42°C in a waterbath in a flat-bottomed container. 
The filter was immersed in this solution and incubated at 42°C with shaking for at least 1 
hour. 
After an hour, the denatured probe was added to the prehybridization solution. Hybridization 
was performed overnight at 42°C with shaking. 
All the washes were performed in a flat-bottomed plastic container with shaking. When 
hybridization was complete, the membrane was removed and immediately placed in a 
container with 2x SSC, 0.1 % SDS. After 20 min at room temperature, the solution was 
replaced with lx SSC, 0.1 % SDS, prewarmed to 50°C. After a further 20 min, this solution 
was replaced with 0.5x SSC, 0.1 % SDS, also prewarmed to 50°C. The membrane was 
washed in this solution for 20 min. 
After the washes, the filter was dried briefly at room temperature on a sheet of 3MM 
Whatman. The filter was then sealed in clingwrap and exposed to pre-flashed X-ray film 
(Hyperfilm MP, Amersham) in a light-excluding cassette to obtain an autoradiographic image. 
The cassette was placed at -70°C. 
3.8 X-ray film development 
After exposure to the membrane, the X-ray film was removed from the cassette and placed 
in developing solution (Metalex, Champion). After approximately 5 min the film was 
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transferred to water for 2 min and then to fixing solution (Fixaplus, Champion) for a further 
2 min. The X-ray film was then rinsed with water and hung up to air dry or alternatively, 
dried in an oven at 50°C for about 5 min. 
3.9 Membrane stripping protocol 
For successful removal of probes, membranes must never be allowed to dry during or after 
hybridization and washing. 
Probe was removed from the membrane by pouring a boiling solution of 0.5% (w/v) SDS 
onto the membrane. This was allowed to cool to room temperature while shaking. To check 
that the probe has been removed, the filter can be autoradiographed for the normal exposure 
time. The filter can then be prehybridized and hybridized with a new probe. 
3 .10 Colony/plaque blotting 
Magna-lift membranes (Micron Separations inc.) were used for colony blots. The colonies 
were grown on gridded LB/ Amp plates. 
The membrane was carefully placed on the agar surface. To ensure correct orientation of 
colonies, the membranes and agar were marked with a sterile needle. The membrane was 
removed after 1 min and placed, colony side up, on a pad (2 pieces thick) of absorbent filter 
paper soaked in denaturing solution (0.5 M NaOH, 1.5 M NaCl). After 7 min the membrane 
was transferred to a pad of absorbent filter paper soaked in neutralizing ( 1.5 M NaCl, 0.5 M 
Tris (pH 7.2), 0.001 M EDTA (pH 8)) solution. The membrane was left for 3 min, and then 
transferred to a fresh pad soaked in the same solution. After a further 3 min, the membrane 
was rinsed briefly (< 60 sec) in 2x SSC, and then fixed by alkaline fixation, as described 
above (section 2.4, Materials and Methods). A second membrane was placed on the agar and 
marked through the hole used to align the first membrane. This membrane was left for 2 min 
before transfer to denaturing solution and the solutions following. 
27 
4. ISOLATION OF PLASMID DNA 
Plasmid DNA was isolated with an alkaline-lysis method. Depending on the amount and 
quality of DNA that was needed, different protocols of isolation were used. 
4.1 Medium-scale (midi-prep) method 
4.1.1 Midi-preps using the Oiagen Plasmid Midi Kit 
The protocol recommended by the manufacturers was followed. 
Overnight cultures (LB or 2x YT) of 100 ml containing the antibiotic of interest (0.1 mg/ml 
ampicillin) was grown. 
To pellet the cells, the overnight culture was centrifuged for 10 min at 10000 rpm. The 
bacterial pellet was then resuspended in 4 ml of buffer Pl , containing RNase A (10 mg/ml). 
To this 4 ml of buffer P2 was added, and the mixture was incubated at room temperature for 
5 min. After 5 min, 4 ml of chilled buffer P3 was added. The sample was then incubated 
on ice for 15 min, and centrifuged at 4°C for 30 min at 2'.: 30000xg. The supernatant was 
removed promptly and applied onto a QIAGEN-tip 100 equilibrated with 4 ml of buffer QBT. 
This was followed with 2x 10 ml washes of buffer QC. The DNA was eluted with 5 ml of 
buffer QF. To precipitate the DNA, 0.7 volumes of isopropanol was added. The sample was 
then centrifuged at 2'.: 15000xg at 4°C for 30 min. The DNA was washed with 5 ml of cold 
70% ethanol, air dried for 5 min, and redissolved in a suitable volume of TE or water. 
4.1.2 Midi-preps using the Nucleobond Plasmid Purification System 
The protocol recommended by the manufacturers was followed. Buffers were supplied by the 
manufacturers. A 100 ml overnight culture containing the antibiotic of interest (0.1 mg/ml 
ampicillin) was grown for the midi-prep. 
To pellet the bacterial cells, the culture was centrifuged at 5000 rpm for 15 min. The 
bacterial pellet was resuspended in 4 ml buffer Sl (50 mM Tris.HCl, 10 mM EDTA, 100 
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µg/ml RNase A, pH 8.0). 4 ml Buffer S2 (200 mM NaOH, 1 % SDS) was added, mixed 
gently, and incubated at room temperature for 5 min. Buffer S3 (2.8 M Potassium acetate, 
pH 5.1), 4 ml, was added, mixed, and incubated on ice for 5 min. The sample was then 
centrifuged at high speed (>lOOOOxg, 4°C). The supernatant was removed from the white 
precipitate, and loaded onto a Nucleobond cartridge equilibrated with 2 ml of buffer N2 (100 
mM Tris, 15% ethanol, 900 mM KCl adjusted with H3P04 to pH 6.3). The cartridge was 
washed with 2x 4ml of buffer N3 (100 mM Tris, 15% ethanol, 1150 mM KCl adjusted with 
H3P04 to pH 6.3). The plasmid DNA was eluted from the column with 2 ml of buffer NS 
(100 mM Tris, 15% ethanol, 1000 mM KCl adjusted with H3P04 to pH 8.5). To precipitate 
the DNA, 0.7 vol isopropanol was added, and the sample was centrifuged at > lOOOOxg at 4°C 
for 30 min. The DNA pellet was washed with 70% ethanol for 10 min. The air-dried pellet 
was then dissolved in a suitable volume of water or TE. 
4.2 Small-scale (mini-prep) method 
4.2.1 Mini-preps using the Wizard Minipreps DNA Purification System 
The protocol suggested by the manufacturers (Promega) was followed. 
A 3 ml overnight culture containing antibiotics (0.1 mg/ml ampicillin) was grown. To pellet 
the cells it was centrifuged for 1 - 2 min at 12000xg at room temperature in eppindorf tubes. 
The pellet was resuspended in 200 µl of cell resuspension solution. To lyse the cells, 200 µl 
of cell lysis solution was added and mixed by inversion. The solution was neutralized with 
200 µl of neutralization solution and mixed by inversion. The sample was then centrifuged 
at 12000xg for 5 min and the supernatant transferred to a new tube. 1 ml of Wizard 
minipreps purification resin was added to the supernatant. For each prep a different column 
was prepared. A 5 ml syringe barrel was attached to the minicolumn and the resin/DNA mix 
was added to the syringe. The syringe plunger was inserted, and the slurry gently pushed into 
the minicolumn. The syringe was detached, and the barrel re-attached to the column. The 
column was washed by pushing 2 ml of column wash solution through. The syringe was then 
removed. The column was transferred to an eppendorf tube and centrifuged for 2 min to dry 
the resin. The column was transferred to a new tube. 50 µl of water/TE was applied to the 
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column. After 1 min the column was centrifuged for 20 sec to elute the DNA. The column 
was removed and discarded. 
4.2.2 Mini-prep method described by Sambrook et al., 1989 
A 1.5 - 5 ml overnight culture was grown, containing the plasmid of interest in LB with 
antibiotics (0.1 mg/ml ampicillin) . Bacterial cells were pelleted by centrifugation at 12000xg 
at room temperature. The medium was removed by aspiration, leaving the bacterial pellet as 
dry as possible. The pellet was resuspended in 100 µJ cold solution I (50 mM Glucose; 25 
mM Tris (pH 8); 10 mM EDTA (pH 8)) by vigorous vortexing. To this 200 J,tl of freshly 
prepared solution II (0.2 N NaOH; 1 % SDS) was added, The sample was mixed by inverting 
the tube, and then placed on ice. 150 J,tl of cold solution III (60 ml 5 M potassium acetate; 
11.5 ml glacial acetic acid; 28.5 ml H20) was added: After gently mixing the sample, it was 
stored on ice for 3 - 5 min. The sample was centrifuged at 12000xg for 5 min at 4 °C. The 
supernatant containing the plasmid DNA was transferred to a fresh tube, where an equal 
volume of phenol/chloroform was added. The sample was mixed well by vortexing, and 
centrifuged at 12000xg for 2 min at 4°C to separate the phases. To precipitate the plasmid 
DNA, 2 vol of room temperature ethanol was added. The sample was then incubated at room 
temperature for 2 min. DNA was precipitated by centrifugation at 12000xg for 5 min at 4°C. 
After removing the supernatant, 70% ethanol was added to wash the pellet. It was then 
centrifuged as described above. The pellet was air dried and dissolved in 50 J,tl TE (pH 8.0) 
containing DNase-free RNase (20 J,tg/ml). 
4.2.3 Mini-prep method described by Stephan et. al., 1990 
Overnight bacterial cultures (3 ml) was grown in selective medium (LB containing 0.1 mg/ml 
ampicillin). The cells were pelleted by centrifugation. The supernatant was removed and 
cells were resuspended in 200 J,tl of a solution of 25 mM Tris (pH 8), 50 mM glucose and 10 
mM EDTA. This was incubated at room temperature for 5 min. A fresh solution of 0.2 N 
NaOH and 1 % SDS ( 400 J,tl) was added to this, mixed by inverting the tube, and incubated 
on ice for 5 min. To this, 300 J,tl of 8 M ammonium acetate was added. After mixing gently, 
the sample was incubated on ice. After 10 min the sample was centrifuged and the 
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supernatant transferred to a fresh tube. To this 0.6 vol of isopropanol was added. After a 10 
min incubation at room temperature, the DNA was precipitated by centrifugation for 10 min. 
The pellet was washed with 75% ethanol, dried, and dissolved in an appropriate amount of 
TE (pH 8.0). 
4.2.4 A PEG precipitation method described by Kraft et al., 1988 
A 3 - 5 ml overnight culture was grown in selective medium (LB containing 0.1 mg/ml 
ampicillin). To pellet the cells, the bacterial culture was centrifuged for 2 min. As much as 
possible of the supernatant was removed, and 100 µl of ice-cold solution I (50 mM Glucose; 
10 mM EDTA; 25 mM Tris-HCl (pH 8)) was added. The pellet was resuspended by 
vortexing. After a 5 min incubation at room temperature, 200 µl of solution II (0.2 N NaOH; 
1 % SDS) was added and the contents of the tube mixed by inversion. 150 µl ice-cold 
potassium acetate (pH 4.8) was added after a 5 min incubation on ice. The sample was 
incubated on ice for another 5 min and then centrifuged for 5 min at 4 °C. The supernatant 
was transferred to a new tube and re-centrifuged. Once again the supernatant was transferred 
to a new tube. RNase A was added to a final concentration of 50 µg/ml. The sample was 
then incubated at 37°C for 30 min to 90 min. After the RNase digestion an equal volume of 
phenol/chloroform was added. The sample was vortexed vigorously and centrifuged for 2 
min. The aqueous phase was transferred to a fresh tube where 2.5 vol of ice-cold 100% 
ethanol was added. The sample was vortexed well and incubated at -70°C for 10 - 30 min. 
To precipitate the DNA, the sample was centrifuged at 4°C for 5 min. The supernatant was 
removed and the pellet was washed with ice-cold 70% ethanol. The pellet was dried under 
vacuum and dissolved in 16.8 µl dH20. To this, 3.2 µl 5 M NaCl and 20 µl 13% PEG was 
added and mixed very well by vigorous vortexing. The DNA was incubated on ice in a cold 
room .{4°C) for a minimum of 30 min, and precipitated by centrifugation at 13000xg for 10 
min at 4 °C. The pellet was washed with cold 70% ethanol, dried under vacuum, and 
dissolved in dH20. 
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4.2.5 A PEG precipitation method described in the PRISM SeguenaseR Terminator Double-
Stranded DNA Sequencing Kit Protocol 
This method yields high-quality, super-coiled plasmid DNA that is relatively free of 
contaminating chromosomal DNA and RNA. Throughout the procedure, the use of a vortex 
must be avoided, so as to minimize shearing of the contaminating chromosomal DNA. 
Samples are mixed by pipeting up and down. The protocol has been modified slightly. 
All manipulations were carried out in 1.5 ml eppindorf tubes. Centrifugation was performed 
at 12000xg at room temperature, unless stated otherwise. 
Overnight cultures were incubated overnight at 37°C in Terrific Broth, with an appropriate 
amount of antibiotic (0.1 mg/ml ampicillin). To pellet the culture, it was centrifuged for 1 
min in a microcentrifuge. After removal of the supernatant, the bacterial pellet was 
resuspended in 200 µl of GTE buffer (50 mM Glucose; 25 mM Tris-HCl (pH 8.0); 10 mM 
EDTA (pH 8.0)). 300 µl of freshly prepared 0.2 N NaOH/1 % SDS was added, and the 
contents of the tube was mixed by inversion until the solution cleared. The sample was then 
incubated on ice for 5 min. The solution was neutralized by adding 300 µl of 3.0 M 
potassium acetate, pH 4.8, mixed by inversion, and incubated on ice for 5 min. Cellular 
debris was removed by centrifuging the sample at room temperature for 10 min, and then 
transferring the supernatant to a clean tube. RNase A (DNase-free) was added to a final 
concentration of 20 µglml and the sample was incubated at 37°C for 20 min. After the RNase 
A treatment, the supernatant was extracted with 3 x 400 µl of chloroform. The layers were 
mixed by hand for 30 s after each extraction. The phases were separated by centrifuging the 
tube for 2 min. The aqueous layer was transferred to a new tube and total DNA was 
precipitated by adding an equal vol of 100% isopropanol and immediately centrifuging the 
tube at room temperature for 10 min. The DNA pellet was washed with 500 µl of 70% 
ethanol and then dried under vacuum for 3 min. The pellet was dissolved in 32 µl of dH20. 
The plasmid DNA was precipitated by first adding 8 µl of 4 M NaCl, and then adding 40 µl 
of autoclaved 13% PEG8000• After thorough mixing, the sample was incubated on ice for at 
least 30 min. The plasmid DNA was then pelleted by centrifugation at 4°C for 30 min. The 
supernatant was removed carefully, and the pellet was rinsed with 500 µl of 70% ethanol. 
The pellet was dried under vacuum for 3 min and resuspended in an appropriate amount of 
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5. RESTRICTION ENDONUCLEASE DIGESTIONS 
Restriction digests were carried out using restriction buffers and enzymes as recommended 
by the manufacturers. The enzyme volumes never exceeded 1/10 of the total reaction volume, 
as the enzyme contains glycerol which may inhibit the reaction. Two restriction enzymes 
could be combined in a single digest provided their salt requirements were compatible. If this 
was not the case, the DNA was first digested with one enzyme, ethanol precipitated and 
dissolved in dH20 , and then digested with the second enzyme. Plasmid DNA was usually 
digested at 37°C for at least 60 min. However, when the restriction enzyme Bell was used, 
incubations were performed at 55°C. 
Reactions were terminated by the addition of 0.2 M EDTA (pH 8.0) or 6x loading buffer and 
analysed by agarose gel electrophoresis. 
6. ISOLATION OF DNA FRAGMENTS FROM AGAROSE 
6.1 Phenol/Chloroform purification method 
Gel slices were melted at 67°C for 10 min. Then 4 - 5 vol of prewarmed (67°C) TE buffer 
were added. The sample was mixed well and kept at 67°C until ready for phenol extraction. 
One vol of phenol was added, whereafter the sample was mixed well by vigorous vortexing. 
The phases were separated by centrifugation at 1600xg for 3 min. The aqueous phase was 
transferred to a fresh tube and 1 vol of phenol/chloroform/isoamyl alcohol (PCI) (25:24:2 
vol/vol) was added. Centrifugation was repeated as described above. The PCI extraction was 
repeated, followed by a chloroform extraction. At this stage the interface was clear. To 
precipitate the DNA, 212 vol 100% ethanol and 1/10 vol of 3 M sodium acetate was added. 
The sample was mixed well and incubated on dry ice. After 10 - 30 min, the sample was 
centrifuged at 15000 rpm for 30 min at 4°C. The pellet was rinsed with 70% ethanol and air 
dried. The pellet was then dissolved in an appropriate vol of dH20. 
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6.2 Wizard PCR preps DNA purification system 
The protocol recommended by the manufacturers (Promega) was followed. 
The agarose slice was incubated at 67°C in a 1.5 ml tube until the agarose was melted 
completely. 1 ml of Magic PCR Preps Resin was added to the melted agarose slice. This 
was mixed by vortexing for 20 sec. For each PCR product, one Wizard minicolumn was 
prepared. The syringe barrel of a 5 ml syringe was attached to the luer-lock extension of each 
column. The Resin/DNA mix was pipetted into the syringe barrel, and the slurry was gently 
pushed into the column with the syringe plunger. After removing the syringe from the 
column and then removing the plunger, the syringe was reattached to the column. 2 ml of 
80% isopropanol was pipetted into the syringe and pushed through the column. The syringe 
was then removed, and the column was transferred to a 1.5 ml tube. The minicolumn was 
centrifuged at 12000xg for 20 sec to dry the resin. The column was transferred to a new 
tube, to which 50 µl of water or TE was applied. After 1 min the column was centrifuged 
at 12000xg for 20 sec to elute the bound DNA fragment. The column was removed and 
discarded and the purified DNA was stored at -20°C. 
7. CLONING OF A PCR PRODUCT 
Amersham's pMOSBlue T-vector kit provides an efficient system for direct cloning of a PCR 
product. The pMOSBlue vector allows for blue-white screening, with recombinant colonies 
appearing white when plated on X-gal (5-Bromo-4-chloro-3-indolyl-,B-D-galactoside) and 
IPTG (Isopropyl-,B-D-thiogalactopyranoside) indicator plates. 
All the cloning was performed using this kit and the solutions provided. The protocol 
recommended by the manufacturers was followed. 
7 .1 Ligation 
For optimal cloning efficiency a vector to insert ratio of 1 : 5 to 1: 10 was used. 
For each PCR product to be cloned, the following ligation reaction was set up : 1 µl lOx 
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ligase buffer, 0.5 µl 100 mM DTT, 0.5 µl 10 mM ATP, 1.0 µl 50 ng/µl vector, "x" µl 
amplified product, and 0.5 µl T4 DNA ligase (2-3 Weiss Units) . The volume was made up 
to 10 µl with nuclease-free water. The ligation reaction was stirred gently with a pipette tip 
and incubated overnight at l 6°C. 
7 .2 Transformation 
Competent cells (MOSB!ue cells supplied in the kit) were thawed on ice and mixed evenly 
to suspend the cells. 20 µl of competent cells was pipetted into a pre-chilled tube and 1 µl 
of ligation mix was directly added to the cells. After mixing gently, the tube was left on ice 
for 30 min. The cells were then heat-shocked for exactly 40 sec in a 42°C water bath and 
immediately placed on ice. After 2 min on ice, 80 µl of room temperature SOC medium was 
added. The tube was then shaken at 200-250 rpm at 37°C for 1 hour. During this hour the 
X-gal/IPTG plates were prepared as follows: 35 µl of 50 mg/ml X-gal and 20 µl 100 mM 
IPTG was spread per L agar antibiotic plate. The plates were then left to soak for at least 30 
min prior to plating. After the 1 hour incubation at 37°C, the 50 µl of the transformation was 
spread onto the L agar plates. The plates were incubated overnight at 3 7°C in and inverted 
position. 
8. PCR SCREENING OF COLONIES 
White colonies were picked off plates with sterile toothpicks and inoculated in 20 µl sterile 
dH20. This was mixed (vortexed) very well. Sterile dH20 containing no bacteria was used 
as controls. To 5 µl of bacterial suspension, the following mix was added: 9.4 µl dH20 , 0.5 
µl 10 mM dNTP, 2 µl lOx PCR Buffer (200 mM Tris-HCl (pH 8.4), 500 mM KCl), 1 µl 
primer 1 (25 pmoles), 1 µl primer 2 (25 pmoles), 0.6 µl 50 mM MgC12, and 0.5 µl Taq DNA 
Polymerase (5U/µl) . This was mixed well. The solution was overlayed with 50 µl of mineral 
oil. The PCR cycle used, was as follows: 30 cycles of 1 min at 94°C, 1 min at 50°C and 1 
min at 72°C. This was followed by a 72°C extension for 10 min. The PCR products were 
analysed by agarose gel electrophoresis. 
9. RNA ISOLATIONS 
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Latex gloves were worn for all manipulations involving RNA. Plugged tips were used at all 
times. Pipettes, centrifuge tubes and homogenizers were treated with 3% H20 2 for an hour, 
rinsed with methanol, washed with DEPC H20 and air dried. They were then autoclaved. 
All solutions used were RNase-free. Water was treated with diethylpyrocarbonate (DEPC). 
The RNA isolations were performed in another laboratory to avoid any contamination. 
9.1 Small scale isolation of Total RNA 
Small scale isolations were performed with the QIAGEN RNeasy Kit. The protocol 
recommended by the manufacturers was followed. 
Lysis buffer RLT was added to the tissue (350 µl buffer to 30 mg tissue) and the tissue was 
then homogenized. A maximum of 600 µl is advised. The sample was then centrifuged for 
3 min at 12000xg. The supernatant was transferred to a clean tube, where 1 vol of 70% 
ethanol was added. The sample was mixed by pipeting. The sample was applied onto a 
RNeasy spin column and centrifuged at 8000xg for 15 min. The column was washed with 
700 µl wash buffer RWl and centrifuged as described above. This was followed by 2x 500 
µl washes with buffer RPE, and centrifugation for 2 min. To elute the RNA, 30 - 50 µl H20 
was applied to the column, followed by 60 sec of centrifugation. 
9 .2 Large scale isolation of total RNA 
Large scale RNA isolations were performed with the guanidine isothiocyanate/acid-phenol 
method. The REX™ Total RNA Extraction Kit (United States Biochemical) was used. The 
protocol recommended by the manufacturers was followed. 
Tissue was homogenized in 10 ml denaturing solution in a hand held homogeniser. After 
homogenization, the following was added: 1 ml 2 M sodium acetate (pH 4.0), 1 O ml water-
saturated phenol, and 2 ml chloroform/isoamyl alcohol (24:1). The sample was shaken well 
and allowed to cool on ice. After 15 min the sample was centrifuged at 1 OOOOxg for 15 min 
at 4°C. The supernatant was transferred to a new tube and re-extracted if necessary. An 
equal volume of 100% isopropanol was added to the sample and it was incubated at -20°C 
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for 1 hour to precipitate the RNA. The sample was then centrifuged at 1 OOOOxg for 15 min 
at 4°C. The RNA pellet was resuspended in 2 ml 4M LiCl. The tubes were then centrifuged 
at 3000xg for 10 min at 4°C to pellet the RNA. The pellet was dissolved in 2 ml REX™ 
Buffer. An equal volume of chloroform/isoamyl alcohol was added, vortexed well, and the 
sample was centrifuged at 3000xg for 10 min. The aqueous phase was transferred to a new 
tube, to which an equal vol of isopropanol was added. After a 15 min incubation at -20°C, 
the sample was centrifuged at lOOOOxg for 15 min. The pellet was rinsed with 5 ml 75% cold 
ethanol, dried under vacuum ( at room temperature) and dissolved in TE. 
9.3 Small scale mRNA isolation 
Small scale isolations of mRNA were performed with Promega' s Poly A Tract mRNA 
Isolation System. This isolation system uses a biotinylated-oligo( dT) probe that is captured 
with a magnet. The protocol recommended by the manufacturers was followed. 
9.3.1 Annealing of probe 
1 mg of Total RNA in a volume of 500 µl was used for mRNA isolation. 
The RNA was denatured by incubation at 65°C for 10 min. 3 µl of biotinylated-oligo( dT) 
probe and 13 µl 20x SSC was added. The sample was mixed gently, and allowed to cool to 
room temperature for annealing of the probe to the RNA. 
9.3.2 Washing of Streptavidin-paramagnetic particles (SA-PMPs) 
The SA-PMP's were resuspended by flicking the tube and captured on the magnetic stand. 
The supernatant was removed carefully. The SA-PMP's were then washed with 3x 0.3 ml 
of 0.5x SSC. After the final wash, the SA-PMP's were resuspended in 0.1 ml 0.5x SSC. 
9.3.3 Capture and washing of annealed oligo(dT)-mRNA Hybrids 
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The entire contents of the annealing reaction was added to the tube containing the washed SA-
PMP's. The tube was incubated at room temperature for 10 min. The SA-PMP's were 
captured on the magnetic stand, and the supernatant was removed. The particles were washed 
with 4x 0.3 ml O.lx SSC. After the final wash, as much as possible of the aqueous phase was 
removed. 
9.3.4 Elution of mRNA 
The final SA-PMP pellet was resuspended in 0.1 ml RNase-free H20 by gentle flicking of the 
tube. The SA-PMP's were captured magnetically. The eluted mRNA aqueous phase was 
transferred to a sterile tube. The elution step was repeated with 0.15 ml H20. The two 
aqueous phases were pooled. 
9.4 RNA concentration and integrity 
RNA concentrations were checked in cuvettes treated with 50 mM NaOH and DEPC H20. 
The integrity of the RNA was checked by denaturing agarose/formaldehyde electrophoresis, 
and visualised by EtBr staining. 
10. cDNA SYNTHESIS 
10.1 Synthesis of double-stranded cDNA 
cDNA was synthesised from human testes RNA with the Clontech Marathon cDNA 
Amplification Kit. Human testes RNA was obtained from post mortem material (adult male, 
- 25 years old) by J. Hapgood, with permission from the UCT Ethics Committee. Two 
different total RNA batches and a poly A RNA batch was used. A control reaction was also 
included. All reactions were performed in 0.5 ml tubes in a thermocycler. The protocol 
recommended in the kit user manual was followed. 
10.1.1 First-strand cDNA synthesis 
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In a 0.5 ml tube, 1 µg RNA, 1 µl 10 µM cDNA synthesis primer, and dH20 to 5 µl were 
added. This was mixed well, spun down, and incubated at 70°C. After 2 min the tubes were 
placed on ice for an additional 2 min. The following mix was then added to the tubes: 2 µl 
5x first strand buffer, 1 µl 10 mM dNTP, 1 µl [a-32P] dCTP (1 µCi/µl), and 1 µl MMLV 
(Moloney Murine Leukemia Virus) reverse transcriptase (100 U/µl). The sample was mixed 
gently by pipetting, and incubated at 42°C for 1 hour. The tubes were then placed on ice to 
terminate the first-strand synthesis. 
[a-32P] dCTP is optional. Addition of the isotope facilitates tracking of the cDNA through 
subsequent steps and troubleshooting cDNA synthesis. 
10.1.2 Second-strand cDNA synthesis 
All components and reaction vessels should be pre-chilled on ice. 
The following mixture was added to the 10 µl of the first-strand reaction: 48.4 µl sterile H20 , 
16 µl 5x second- strand buffer, 1.6 µl 10 mM dNTP mix, and 4 µl 20x second-strand enzyme 
cocktail. The contents was mixed thoroughly by gentle pipetting. The tubes were spun 
briefly to collect the contents at the bottom. The tubes were then incubated at l 6°C. After 
90 min, 2 µl (10 U) T4 DNA polymerase was added. The contents was mixed by pipeting. 
The tubes were then incubated at 16°C for a further 45 min. To terminate second-strand 
synthesis, 4 µl EDTA/glycogen mixture was added. 100 µl PCI was added to this and 
vortexed thoroughly. The tubes were then centrifuged at 14000 rpm for 10 min. The 
supernatant was transferred to a new tube, where 100 µl of chloroform/isoamyl alcohol (24: 1) 
was added. The sample was mixed well and then centrifuged at 14000 rpm for 10 min. The 
supernatant was transferred to a clean tube. To precipitate the DNA, Yi vol 4 M ammonium 
acetate and 2 Yi vol 95% room temperature ethanol was added. The sample was vortexed 
thoroughly and centrifuged at 14000 rpm for 20 min at room temperature. The supernatant 
was removed carefully. If the DNA precipitated efficiently, the pellet should contain 1-10% 
of the total radioactivity in the sample. The pellet was rinsed with 300 µl of 80% ethanol and 
centrifuged at 14000 rpm for 10 min. The pellet was air dried, and dissolved in 10 µl of 
H20 . 
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The yield and size of the ds cDNA was estimated by comparing it to the positive control. 
This was done by running 2 µl of the cDNA on a 1 % agarose gel. 
The agarose gel was dried using a vacuum gel drying system and exposed to X-ray film. 
10.1.3 Adaptor ligation 
This procedure uses 5 µl of the 10 µl ds cDNA obtained after second-strand synthesis. The 
5x ligation buffer must be completely thawed at room temperature for at least 30 min before 
use. 
The following mixture was combined in a 0.5 ml tube: 5 µl ds cDNA, 2 µl Marathon cDNA 
Adaptor (10 µM), 2 µl 5x DNA ligation buffer, and 1 µl of T4 DNA ligase (1 U/µl). The 
contents was mixed by vortexing, and incubated overnight at l 6°C, after which the ligase was 
inactivated by heating the tube to 70°C for 5 min. The adaptor-ligated ds cDNA was diluted 
with Tricine-EDTA buffer and stored at -20°C. 
10.2 Synthesis of single-stranded cDNA 
cDNA was synthesised from testes poly A RNA template with the Gibco BRL 5'RACE 
System for Rapid Amplification of cDNA Ends (See figure 22). 
10.2.1.1 First-strand cDNA synthesis - SuperScriptII RT 
This procedure is designed to convert specific RNA sequences from a background of up to 
1 µg of total RNA into first strand cDNA. 
cDNA was synthesised from 1 µg of poly A RNA isolated from human testes. RNA (S 1 
µg), 1 µl (2.5 pmoles) gene specific primer 1 (GSPl), and DEPC-treated H20 sufficient for 
a final volume of 14 µl were added to a 0.5 ml tube. The mixture was incubated at 70°C for 
5 to 10 min to denature RNA. After chilling the tube on ice for 1 min, it was centrifuged 
briefly to collect the contents of the tube. The following mixture was then added: 2.5 µl lOx 
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reaction buffer (200 mM Tris-HCl (pH 8.4), 500 mM KCl), 3 µl 25 mM MgC12, 1 µl 10 mM 
dNTP mix, 2.5 µl 0.1 M DTT, and 1 µl RNase inhibitor. The mixture was mixed gently and 
incubated at 42°C for 2 min, after which 1 µl of SuperScript II RT was added. After gentle 
mixing, the tube was incubated at 42°C for 30 min, and then placed at 65°C - 70°C. After 
15 min, the tube was centrifuged briefly to collect the contents, and then placed at 55°C. To 
degrade the mRNA template, 1 µl of RNase H was added. After a further 10 min incubation 
at 55°C, the reaction was collected by brief centrifugation, and the tube was placed on ice. 
10.2.1.2 First-strand cDNA synthesis-Expand™ RT (Boehringer Mannheim) 
cDNA was synthesised from 1 µg of poly A RNA. RNA (:S 1 µg), 1 µl (2.5 pmoles) GSPl, 
and DEPC-treated H20 sufficient for a final volume of 12.5 µl were added to a 0.5 ml tube. 
The mixture was incubated at 70°C for 10 min to denature RNA. After chilling the tube on 
ice for 1 min, it was centrifuged briefly to collect the contents of the tube. The following 
mixture was then added: 5 µl 5x Expand buffer (2.5 mM MgC12, 20 mM KCl, 25mM Tris), 
2.5 µl 100 mM DTT, 2.5 µl 10 mM dNTP mix, 2 µl Expand RT (100 units), and 0.2 µl 
RNase inhibitor (RNaseln) (101 U/µl). The solution was mixed gently and collected by 
centrifugation. The tube was then incubated at 42°C for 60 min, followed by a 15 min 
incubation at 68°C. After a quick spin, the tube was placed at 55°C, lµl of RNase H was 
added, and the tube was incubated for 10 min. The contents of the tube was then collected 
by brief centrifugation, and the tube was placed on ice. 
10.2.2 Purification of cDNA 
cDNA was purified with Promega's Wizard PCR preps DNA purification system. The 
protocol recommended by the manufacturers was followed. 
1 ml of Magic PCR Preps Resin was added to the cDNA. This was mixed by vortexing for 
20 sec. For each cDNA sample, one Wizard minicolumn was prepared. The syringe barrel 
of a 5ml syringe was attached to the luer-lock extension of each column. The Resin/cDNA 
mix was pipetted into the syringe barrel, and the slurry was gently pushed into the column 
with the syringe plunger. After removing the syringe from the column and removing the 
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plunger, the syringe was reattached to the column. 2 ml of 80% isopropanol was pipetted into 
the syringe and pushed through the column. The syringe was then removed, and the column 
was transferred to a 1.5 ml tube. The minicolumn was centrifuged at 12000xg for 20 sec to 
dry the resin. The column was transferred to a new tube, and 50 µl of water or TE (pH 8.0) 
was added. After 1 min the column was centrifuged at 12000xg for 20 sec to elute the bound 
cDNA. The column was removed and discarded. After elution, the sample was placed in a 
vacuum drier until the volume was reduced to 10 µl. 
10.2.3 TdT Tailing of cDNA 
The following mixture was added to the cDNA sample: 7.5 µl DEPC-treated H20, 2.5 µl lOx 
reaction buffer (200 mM Tris-HCl (pH 8.4), 500 mM KCl), 1.5 µl 25 mM MgC12, and 2.5 
µl 2mM dCTP. The sample was then incubated at 94 °C. After 3 min the tube was transferred 
to ice for a further 1 min. To collect the contents of the tube, it was centrifuged briefly. 1 
µl of TdT (10 U/µl) was added to the tube and the contents mixed gently. The mixture was 
incubated at 3 7°C for 10 min. The T dT was heat inactivated by incubation at 65-70°C for 
10 min. The contents of the tube was collected by brief centrifugation. 
11. SEQUENCING OF DOUBLE-STRANDED TEMPLATES 
All the kits use the chain-terminating DNA sequencing method. 
Different sequencing kits were used for sequencing plasmid DNA. 
11.1 IsoTherm TM DNA Sequencing Kit {Epicentre Technologies) 
11.1.1 Alkaline denaturation of template 
2 µg of plasmid DNA in a total volume of 10 µl was used as template. 10 µl of 0.4 N 
NaOH, 0.4 mM EDTA was added to this and mixed gently. The sample was then incubated 
at 65° for 15 min, after which the following were added: 2 µl 2 M ammonium acetate (pH 
4.5), and 50 µl room temperature 95% ethanol. The sample was incubated at room 
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temperature for 5 mm, and then centrifuged for 5 mm. The supernatant was removed 
carefully, and the pellet was washed with 70% ethanol, dried, and resuspended in 8 µJ H20 . 
11.1.2 Sequencing protocol 
0.5 pmol primer and 1.0 µ.l 1 Ox reaction buffer were added to the denatured dsDNA. The 
tube containing this mixture was labelled as the "premix" tube. It was incubated at 70°C for 
5 min. The mixture was then allowed to cool to room temperature on the benchtop. Then 
1.0 µ.l IsoTherm DNA Polymerase and 1.5 µ.l [a-35S]dATP (5 µ.Ci) was added to the premix 
and mixed gently. 2 µ.l of each termination mixture was transferred to a clearly labelled tube, 
and 3 µ.l of premix was added to each termination tube. The tubes were then incubated at 
65°C. After 2 min 2 µ.l of Chase Mix was added. The tubes were incubated at 65°C for a 
further 2 min. The reaction was stopped by adding 4 µ.l stop/loading buffer to each reaction. 
Before loading the samples on a sequencing gel, they were incubated at 70°C for 5 min. 
11.2 T7 Seguenase Quick Denature Plasmid Sequencing Kit 
This kit is made especially for plasmid DNA, and includes solutions for denaturing of the 
template. The protocol recommended by the manufacturers was followed. 
11.2.1 Alkaline Denaturation 
0.5 - 3 µ.g of DNA in a maximum volume of 8 µ.l was used as a template. 2 µ.l 1.0 M NaOH, 
1 µ.l primer (0.5-2 pmol), and H20 to 11 µ.l were added to the template. After thorough 
mixing, the sample was incubated at 37°C for 10 min, and then placed on ice. 2 µ.l 1.0 M HCl 
and 2 µ.l plasmid reaction buffer were added to the sample. 
11.2.2 Annealing 
To allow the primer to anneal, the template/primer/buffer mixture was incubated at 37°C for 
10 min, and then placed on ice. 
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While annealing, preparations for the labelling were done. The labelling mix was diluted 5-
fold with water, and 2.5 µl of each of the termination mixtures were transferred to clearly 
labelled tubes. The termination tubes were pre-warmed at 37°C. 
11.2.3 Labelling reaction 
The following mixture was added to the ice-cold annealed DNA mixture: 1 µl 0.1 M DTT, 
2 µl diluted labelling mix, 0.5 µl [a-35S] dATP (5 µCi), and 2 µl T7 Sequenase plasmid 
sequencing formulation. The sample was mixed well and incubated at room temperature for 
2 to 5 min. 
11.2.4 Termination reactions 
4.5 µl of labelling reaction was transferred to each termination tube and mix. The mixture 
was incubated at 37°C for a further 5 min. To stop the reaction, 4 µl of stop solution was 
added. The samples were heated to 75°C for 2 min immediately before loading onto a 
sequencing gel. 
11.3 Sequenase Version 2.0 DNA Sequencin2 Kit 
Two different protocols were followed when sequencing with this kit. They are both slight 
modifications of the protocol recommended by the manufactures. 
11.3.1 Standard sequencing protocol 
11. 3 .1.1 Denaturing 
Two different methods were used for denaturing plasmid DNA 
11.3 .1.1.1 Denaturation of plasmid DNA by boiling 
Plasmid DNA (3-5 µgin a maximum volume of 7 µl) was denatured by boiling the sample 
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for 3 min and then snap-freezing it on dry ice for 30-60 sec. The sample was then spun 
briefly to collect the contents of the tube. 
11.3.1.1.2 Alkaline denaturation of plasmid DNA 
5 µg of plasmid DNA in a total volume of 10 µl was used as template. 10 µl of 0.4 N 
NaOH, 0.4 mM EDTA was added to this and mixed gently. The sample was then incubated 
at 65° for 15 min, after which the following was added: 2 µl 2 M ammonium acetate (pH 
4.5), and 50 µl room temperature 95% ethanol. The sample was incubated at room 
temperature for 5 min, and then centrifuged for 5 min. The supernatant was removed 
carefully, and the pellet was washed with 70% ethanol, dried and resuspended in 7 µl H20. 
11.3.1.2 Annealing 
1 µl primer (10 ng), 2 µl reaction buffer, and H20 to 10 µl were added to the plasmid DNA. 
The mixture was incubated at 3 7°C for 15 min for annealing of the primer to the template, 
and then placed on ice. 
During the 15 min annealing, solutions were prepared for the labelling reaction. 2.5 µl of 
each termination mix was transferred to a clearly labelled tube. These tubes were incubated 
at 37°C for at least 1 min. Labelling mix was diluted 5-fold with H20. The Sequenase 
Version 2.0 enzyme was diluted 1:8 in ice-cold enzyme dilution buffer. 
11. 3 .1. 3 Labelling reaction 
The following mixture was added to the annealed template-primer (on ice): 1.0 µl 0.1 M 
DTT, 2.0 µl diluted labelling mix, 0.5 µl [a-35S]dATP, and 2.0 µl diluted Sequenase. The 
sample was mixed thoroughly and incubated at room temperature for 2 to 5 min. 
11. 3 .1.4 Termination reaction 
When labelling was complete, 3.5 µl of mix was removed and transferred to the tubes 
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containing the termination mixes. These were then incubated at 3 7°C for a further 5 min. 
To stop the reaction, 4 µJ of stop solution was added to each termination reaction and mixed 
thoroughly. The samples were heated to 80°C for 2 min just before loading on a sequencing 
gel. 
11.3.2 A modified sequencing protocol using DMSO 
This protocol is basically the same as the one described above, except for the use of DMSO. 
DMSO is added to the sequencing reaction for clearer, darker bands on the autoradiograph. 
This method was obtained from Brigitte Blackman. 
11 .3 .2.1 Alkaline denaturation of template 
1 µl of 2 M NaOH was added to 9 µl DNA (3-5 µg) and mixed well. The sample was 
incubated at 37°C for 15 min, after which 10 pmoles of primer (1 µl of 10 µM stock) was 
added. The sample was vortexed briefly. To neutralize the NaOH, 3 µl of 3M potassium 
acetate was added. To precipitate the DNA, 75 µl of ethanol was added. The sample was 
then centrifuged at 13000 rpm for 10 min. The pellet was washed with 100 µl of 75% 
ethanol and dried under vacuum. 
11.3.2.2 Sequencing protocol 
The pellet was resuspended in 8 µl H20 and 2 µl reaction buffer. The termination mixes were 
prepared as follows: 2.5 µl termination mix and 0.25 µl DMSO were combined in a tube and 
prewarmed to 45°C. The following mixture was added to the sample: 1 µl DTT, 2 µl diluted 
labelling mix, 0.5 µl [a-35S] dATP (5 µCi), 2 µl diluted Sequenase, and 1.7 µl DMSO. The 
sample was incubated at room temperature for 5 min, after which 4.3 µl of mixture was 
transferred to each of the termination mixes. The samples were incubated at 45°C for 5 min. 
To stop the reaction, 5 µl of stop solution was added. The samples were heated to 80°C for 
2 min before loading on a sequencing gel. 
11.4 Denaturing acrylamide gel electrophoresis 
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Samples were run on a 6% acrylamide, 7 M urea gel in lxTBE at 90 Watts. Gels were 0.46 
mm thick. Gels were run between 1 Vi to 4 hours. 
5.7 g acrylamide, 0.3 g bisacrylamide, 42 g urea, and 20 ml 5xTBE were combined in a 
beaker. H20 was added to a volume of 100 ml. The solution was mixed until dissolved, and 
then filtered. 100 µl TEMED and 1 ml 10% ammonium persulfate were added to the mixture 
before pouring the gel. 
12. POLYMERASE CHAIN REACTION (PCR} 
All PCR reactions were set up in a laboratory where no post-PCR products or plasmids were 
present. Gloves were worn at all times, and frequently changed. Plugged tips were used for 
all reactions to avoid aerosol contaminants. Typically, 50 µl reactions were set up. The 
reaction mixture and PCR cycling conditions varied with the template and primers used. 
For amplification of gDNA with degenerate primers, the following reaction was used: 1 µl 
10 mM dNTP, 5 µl lOx reaction buffer (200 mM Tris-HCl (pH 8.4), 500 mM KCl), 2 - 3 µl 
50 mm MgC12, 0.25 - 1 µg of each primer (depending on the degeneracy of the primer, 0.5 
µl Taq (5U/µl Taq DNA from Thermus aquaticus YTl, Gibco BRL), 1 µg gDNA, and sterile 
water to 50 µl. The reaction mixture was covered with 50 µl mineral oil. The following PCR 
cycle was used: 94°C for 1 min (denaturation), followed by 55°C for 2 min for annealing of 
the primer, and 3 min at 72°C for the extension of the product. Typically, 35 cycles were 
performed. 
For amplification of cDNA with gene specific primers the following reaction was used: 1 µl 
10 mM dNTP, 5 µl lOx reaction buffer (400 mM Tricine -KOH (pH 9.2), 150 mM potassium 
acetate, 35 mM magnesium acetate, 750 µg/ml bovine serum albumin), 10 - 20 µM of each 
primer, 1 µl 50x Klentaq polymerase mix (KlenTaq-1 DNA polymerase, TaqStart Antibody), 
cDNA, and sterile water to 50 µl. Touchdown cycling conditions were normally used, in 
order to maximize the specificity of the reaction. The typical PCR cycle was as follows: 94 
°C for 1 min, followed by 5 cycles of 94°C for 30 sec, 72°C for 4 min. This was followed 
by another 5 cycles of 94°C for 30 sec, 70°C for 4 min, followed by 25 cycles of 94°C for 
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30 sec, 68°C for 4 min. This was followed by a 10 min extension at 72°C. 
13. ELIMINATING CONTAMINATION DURING PCR 
All the solutions used were aliquoted into small aliquots when opened. PCR reactions were 
set up in another laboratory, where nobody worked with the GnRHR, or any other plasmids. 
The PCR solutions were also stored in this laboratory. All the reactions were performed with 
plugged tips, to avoid aerosol contaminants. The set of pipettes used to set up the reactions, 
were used for PCR only. The tips, as well as the eppendorf tubes, were stored in a UV-
lightbox. Also, gloves were changed frequently. When setting up a PCR reaction, a negative 
(no DNA) control was always included. An icebox was also set apart for the sole purpose 
of setting up PCR reactions. 
To minimize template contamination, all genomic DNA isolations were performed in another 
laboratory, with sterile solutions and plugged tips. The tubes containing the genomic DNA 




1. OPTIMISATION OF DEGENERATE PRIMERS 
A series of degenerate primers was designed to the type I GnRHR sequences that were 
conserved between different mammalian receptors (J. Hapgood) (Figure 9). 
exon I exon 2 exon 3 
GENE intron I intron 2 
mRNA transcript 
TM I TM 2 






<t- Antisense primers 
~ Sense primers 
JH 3a JH 4s JH 5s JH 6al 
JH 5a JH 6a2 
Figure 9 Schematic diagram to indicate the relation of the degenerate primers to the type 
I human GnRHR gene. 
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The different primer pairs were tested on human gDNA. Mouse GnRHR cDNA was used as 
a positive control, since we knew what size PCR product to expect. The primers were 
originally designed to mammalian type I GnRHR. If the primers did not work on human 
gDNA and mouse GnRHR cDNA (in other words if this did not produce a PCR product of 
the expected size), we did not expect them to work on redbait gDNA, or any other species' 
gDNA. The PCR was performed twice, in order to confirm our results. PCR products of the 
expected size, i.e. 134 bp, 170 bp, 309 bp, 120 bp, 233 bp, and 95 bp, were obtained with 
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Figure 10 The photographs represent 2 independent 
experiments. Different combinations of degenerate 
primer pairs were tested on human gDNA. 20 µl of 
PCR product was electrophoresed on a 1. 5 % agarose 
gel. A 123 bp ladder is included as a molecular 
weight marker. The 1st of each group of 3 lanes is the 
PCR performed on human gDNA, (-) indicates a 
negative control (no DNA or water blank), and (+) 
indicates a positive control PCR performed on mouse 
GnRHR cDNA. Bands obtained that were of the 
expected size are marked. Primer pair A = 5S/6A2, 
B = 4S/6A2, C = 1 S/3A, D = 2S/3A, E = 1 S/2A, and 
F = 4S/5A. 
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All the primer pairs tested produced bands of the expected size, although some primer pairs 
produced better results than others (a clearer band on the EtBr-stained agarose gel). Note that 
a band of the expected size can be seen in lane 2 of A in the first photograph whereas in the 
second photograph that lane is clear. The opposite is seen in C where a band is seen in the 
negative control sample in the second photograph but not in the first. The bands present in 
the negative controls are due to contamination, which despite taking all proper precautions 
could sometimes not be avoided (See section 13, Materials and Methods). These results 
established that the degenerate primers were able to specifically amplify the GnRHR 
sequences from human gDNA and mouse GnRHR cDNA. 
2. ISOLATION OF A PUTATIVE REDBAIT GnRHR GENE WAS 
UNSUCCESSFUL 
Genomic DNA (gDNA) was isolated from the redbait gonads as described in Current 
Protocols in Molecular Biology. To assess the integrity of the gDNA, 1 µg of DNA was run 
on an analytical agarose gel with a molecular weight marker (Figure 11 ). 
The DNA was mostly > 11.5 kb, therefore DNA did not appear to be degraded. PCR was 
performed on the redbait gDNA with degenerate primers designed to areas of the GnRH 
receptor that are highly conserved between different mammals. Six different combinations of 
primers were tested. They are IB5S + IB6A2, IBIS+ IB3A, IB2S + IB3A, IBIS+ IB2A, 
IB4S + IB5A and IB4S + IB6A2. The PCR products were checked by electrophoresis on an 
analytical agarose gel. Only primer pairs 1 S/2A (233 bp ), 4S/5A (95 bp) and 4S/6A2 (170 
bp) showed products of the expected size (Figure 12). Primer pairs 5S/6A2, 1S/3A, 2S/3A 
did not appear to work (did not produce a PCR product of the expected size). A Southern 
blot was performed on this gel (Figure 13), probing the membrane with human type I GnRHR 
cDNA probe (See preparation in section 2.5, Materials and Methods). 
11.5 kb 
5.08 kb 
Figure 11 1 µg of redbait genomic DNA 
(right lane) was electrophoresed on a 0.6% 
EtBr-stained agarose gel. A DNA digested 
with Pst I is used as a size marker (left 
lane). 
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The 1 S/2A and 4S/5A products gave a clear positive signal on the autoradiograph, and the 
4S/6A2 a weaker signal. These products were also checked by restriction enzyme digestions, 
to check if the positive signals were contamination, or if they were real. The logic behind 
the use of restriction enzyme digestions as an analytical tool, is that different GnRH receptor 
species are bound to differ in some of the restriction enzyme sites. By doing digestions with 
a few different enzymes, we would be able to tell if our isolated fragments differed from 
mouse and human GnRH receptor, by looking at the pattern of the digested DNA. The 
products of restriction enzyme digestions were different to mouse and human digests, 
suggesting that the products were not mouse or human contaminants (data not shown). 
Subsequent PCR reactions performed on redbait gDNA with primer pair 5S/6A2, did produce 
a product of the expected size, i.e. 134 bp ( data not shown). 
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These PCR products were isolated by electrophoresis on a low melting agarose gel and 
excision of the fragments of interest. The 1 S/2A and 4S/6A2 PCR products were cloned into 
pMOSBlue T-vector and transformed into pMOS bacterial cells. 4S/5A PCR products were 
not cloned, since it proved difficult to obtain sufficient product for cloning. 
In order to obtain sufficient DNA for further analysis of the cloned products, small-scale 
isolation of plasmid DNA was performed. These plasmids were then digested with restriction 
enzymes and checked by Southern blot. The Southern was probed with a human GnRHR 
cDNA probe, stripped, and reprobed with a mouse PCR-radiolabelled GnRHR cDNA probe. 
The digestion of the plasmids differed from the human and mouse cDNA digestions, 
indicating that we did not have any mouse or human contamination. We then sequenced 
several of the samples, in order to find out exactly what we had isolated. The sequencing 
data was analysed by comparison to the human GnRHR sequence. The same cloning strategy 
was followed for 5S/6A2 PCR products. 







Figure 12 PCR on redbait genomic DNA using different 
combinations of degenerate primers. The bands obtained that were 
of the expected size are marked. Lane M contains the 123 bp 
marker. Primers used were, A= 5S/6A2, B = 1S/3A, C = 2S/3A, 
D = 1 S/2A, E = 4S/5A, and F = 4S/6A2. The first of each group 
of 3 lanes is the PCR performed on redbait gDNA, (-) indicates a 
negative control (no DNA or water blank), and ( +) indicates a 
positive control PCR performed on mouse GnRHR cDNA. 
Primer pair A B C D E 






Figure 13 Autoradiograph of a Southern blot performed 
on the gel in Figure 12. PCR was performed on redbait 
gDNA using different combinations of degenerate 
primers (See Figure 7). A Southern blot was performed 
on this gel, probing with human type I GnRHR cDNA. 
The first lane of each primer pair is the PCR performed 
on the redbait gDNA, (-) is the negative (no DNA) 
control, and ( +) is the PCR performed on mouse 
GnRHR cDNA (positive control). The expected sizes 
for the different primer pairs are as follows: 5S/6A2 -
134 bp; 1S/3A - 309 bp; 2S/3A - 120 bp; 1S/2A - 233 
bp; 4S/5A - 95 bp; 4S/6A2 - 170 bp. These signals are 
clearly visible as large overexposed "blobs" for the 
positive control lanes for mouse cDNA. The figure 
clearly shows the positive signals obtained for redbait 
gDNA with primer pairs 1S/2A (D)(233 bp), 4S/5A 
(E)(95 bp), and 4S/6A2 (F)(l 70 bp). No bands were 
visible with redbait gDNA for primer pairs 5S/6A2 (A), 
1 S/3A (B), and 2S/3A (C). No positive signals were 
visible for the negative controls, indicating that there 
was no contamination of PCR reactions. Lines indicate 
bands obtained that were of the expected size. 
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Another way of analysing the cloned colonies, was by use of direct PCR of the colonies with 
primers located in the vector. We used primer pair T7 and U19, which are located in the 
polylinker of the pMOSBlue T-vector. This primer pair was a very handy tool, since it 
allowed us to immediately identify the size of our cloned PCR fragments. These PCR 
products were transferred to Hybond N+ by Southern blot, and probed with type I chicken 
GnRHR1• Positive colonies were sequenced. 
A total of 43 1 S/2A colonies, 34 4S/6A2 colonies, and 36 5S/6A2 colonies were sequenced. 
The sequencing data was analysed on GCG by comparison to the human GnRH receptor 
sequence. Unfortunately, most of the 5S/6A2 colonies were contaminating Xenopus or 
Goldfish GnRHR2• Several of the colonies were not contaminants, but were found not to be 
related to GnRHR or any other previously identified protein in the database. 
3. ISOLATION OF EXON 1 OF TYPE I GnRHR GENE FROM MOLE 
GENOMIC DNA 
Genomic DNA (gDNA) was isolated from mole gonads by the method described by Ausubel 
et al., 1987, in Current Protocols in Molecular Biology. From 600 mg of tissue 2.6 mg of 
gDNA was isolated. The quality of the gDNA was analysed by agarose gel electrophoresis. 
After the integrity of the DNA was confirmed, PCR was performed on mole gDNA with 
primer pair llilS + lli2A. In order to find the optimum conditions for amplification of the 
1The Type I GnRHR was cloned from chicken gDNA by with degenerate primer 
pair 5S/6A2 by Yuh-man Sun. 
2In parallel to this study, other researchers in the laboratory were busy cloning 
Xenopus and Goldfish GnRHRs using the same degenerate primers. It is possible that the 
primers became contaminated with plasmid or PCR products present in the laboratory 
(Section 11, Materials and Methods). 
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1S/2A fragment, an increasing concentration range of MgC12 (from 2 mM to 3.5 mM) was 
used in the PCR experiment. Primer pair 1 S/2A is designed to amplify a 23 3 bp fragment 
of exon 1 from TMl to TM2. Upon analysis of PCR products on an analytical agarose gel, 
a fragment of the expected size was detected (Figure 14). 
246bp 
123 bp 
mole - control 
M .. ,--... 11 
• 
Figure 14 PCR was performed on mole gDNA, and no DNA 
as negative control (- control) with primer pair JHl S + JH2A. 
20 µJ of each 50 µl PCR reaction was loaded on an EtBr-
stained 1.5 % agarose gel. A 123 bp ladder was used as a size 
marker (lane M). Four lanes can be seen for each sample. 
This is four different MgC12 concentrations, i.e. 2 mM, 2.5 
mM, 3 mM, and 3.5 mM. The arrow indicates a band of 
approximately 240 bp. No bands were visible in the negative 
(no DNA) control, indicating that there were no contaminants 
in the PCR. 
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The remaining PCR mixture was pooled and the fragment of interest (233 bp) was isolated 
by electrophoresis on a low melting point agarose gel and excision. The DNA was purified 
from the agarose by the phenol/chloroform extraction method (Section 5.1, Materials and 
Methods), and dissolved in water. With the use of the pMOSBlue cloning kit, the DNA was 
ligated into the pMOSBlue T-vector, and transformed into pMOS bacteria.For further analysis 
of the PCR generated inserts, twenty colonies were picked at random and subjected to plasmid 
preparations to obtain sufficient DNA for analysis by DNA sequencing (Figure 15). 
The sequencing data obtained was analysed by comparison to the human type I GnRHR. 
Comparisons were done on both the DNA level, and the amino acid level. The comparisons 
revealed that six (30%) of the total of twenty colonies sequenced, were exon 1 of the mole 
type I GnRHR. The remaining fourteen (70%) colonies all contained inserts that were non-
specific amplifications. Sequence analysis revealed that exon 1 of the mole type I GnRHR 
is 89.5% homologous to human GnRHR on the DNA level, and 93% on the amino acid level 
(Figure 16). 
GATC GATC 
Figure 15 The 233 bp PCR 
products shown in Figure 14 
were cloned into a vector. 
Several colonies were picked 
and plasmid DNA was isolated. 
The DNA was sequenced by 
the Sanger di-deoxy method 
with 35S and exposed to film. 
An autoradiograph of the 
sequencing gel is shown. The 
2 sequences represent 2 
identical sequences of 2 
representative mole clones. 
Part of exon 1 of the mole 
GnRHR DNA sequence (see 
Figure 16) is visible. 
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DNA sequence comparison: 
Human: GGAAAGATCCGAGTGACGGTTACTTTCTTCCTTTTTCTGCTCTCTGCG 
Mole : GGTAAGATTAGGGTGACAGCTACTTTCTTCCTTTTTCTACTTTCCACA 
0-+ 
Human: ACCTTTAATGCTTCTTTCTTGTTGAAACTTCAGAAGTGGACACAGAAG 
Mole : ACTTTTAATGCTTCTTTCTTGTTGAAACTTCAGAAGTGGACTCAAAAG 
Human: AAAGAGAAAGGGAAAAAGCTCTCAAGAATGAAGCTGCTCTTAAAAC 
Mole : AAAGAGAAAGGGAAAAAGCTCTCAAGAATGAAGGTGCTTTTAAAAC 
4-0 
Human: ATCTGACCTTAGCCAACCTGTTGGAGACTCTGATTGTCATGCCACTGG 
Mole : ATCTGACCTTAGGCAATCTGTTGGAGACTCTGATTGTCATGCCATTGG 
Human: ATGGGATGTGGAACATTACA 
Mole : ATGGAATGTGGAACATCACC 
Amino Acid Comparison: 
Human: GKIRVTVTFFLFLLSATFNASFLLKLQKWTQKKEKGKKLSRMKLLL 
Mole : GKIRVTATFFLFLLSTTFNASFLLKLQKWTQKKEKGKKLSRMKVLL 
Human: KHLTLANLLETLIVMPLDGMWNITVQ 
Mole : KHLTLGNLLETLIVMPLDGMWNITVH 
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Figure 16 Part of exon 1 of mole GnRHR consensus sequence derived by comparison of 6 
individual clones. Differences between the mole and human sequences are highlighted. 
Underlined sequences indicate the primers that were used in the PCR reactions. The DNA 
sequence corresponding to the sequence on the autoradiograph in Figure 15 is marked (0 -+ to 
t- 0 ). 
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4. IDENTIFICATION AND CLONING OF PART OF A TYPE II GnRH 
RECEPTOR GENE IN HUMANS. 
4.1 Detection of a type II GnRH receptor cDNA in the database by homology searches 
Human genome data bases were searched for a type II GnRH receptor homologue (D. 
Conklin). The searches were performed with the sequence of a putative type II GnRHR from 
reptile (E. Rumback, personal communication). The type II GnRHR in reptile differs quite 
strikingly in amino acid composition and length from mammalian type I GnRHR in 
extracellular loop 3 (EC 3). The searches revealed the presence of antisense human type II 
GnRHR EST cDNA clones in several human tissues, showing that a gene for a type II 
GnRHR exists in the human genome. The novel type II sequences obtained in the data base 
corresponded to exons 2 and 3 of the type I human GnRHR, and contained an intron 
corresponding to intron 2 of type I human GnRHR (Figure 17). A series of gene specific 
primers was designed (See Figure 18) to the sequence found in the database (R.P. Millar). 
Finding these cDNA sequences in the data base raised the following questions: 
(i) Is the "sense" RNA (i.e. minus intron) actually expressed in human tissues? 
(ii) In which tissues is the sense RNA expressed? 
(iii) Does the full length cDNA contain the equivalent of exon 1 of the type I GnRHR? 
(iv) Is there a mouse equivalent type II GnRHR? 
I attempted to answer some of these questions as part of this MSc thesis. 
1 gcatttggaa aatgttaaat tttattattt aacattcttt accattatag 
51 ttactgcaca taagactatt actactaaag gtcacttcag agtccctgca 
101 aaatggcctg gaattttggc agcacccatt ttacacaata tttctttttc 
151 cacaaaataa cagacatacc aggaaaatca tttcagctaa aaatatgagt 
201 gaggtggtag aaatatcatc ccttataaag cgcaatgtta gaatagtact 
251 tgagaaagca ggattgtttt aagttccaag atttaacaaa cttactgttc 
301 agcatcatat tcaagcctaa aaggaagata ggattttcaa gatatatttc 
351 caacttcttt aacatggcac catggatgaa ctgtttctca gcactgtgct 
401 gcttcacttg gaattaagga tgaattggga ggagacagta tgacataggt 
451 gggtatgttg ggtggtgagg ggaaccagtt ctaatagtcc tcaacttcca 
501 ctccagctgt tcctgttcca cacggtccac tgagctggcc cagtcccttt 
~JHE2 ~10242 
551 cactcagtgt gtcaccaaag gcagcttcaa ggctcaatgg caagagacca 
601 cctataacct cttcaccttc tgctgcctct ttctgctgcc actgaactgc 
651 catggccatc tgctatagcc gcattgtcct cagtgtgtcc aggccccaga 
• 701 caaggaaggg gagcccatgg tgagactcaa ttcccaggcc ttaatcctta 
751 accctagacc tgttgcctct agcatcattt atttacctcc ctaccctaag 
801 agctatctac cagtacctaa accatggtga gattctaacc atgtctagca 
851 cctgatgcta gagataattt tgttgaatcc cttcaattat aaacagctga 
901 gttagctgga caaggactag ggaggcaatc agtattattt attcttgaac 
951 accatcaagt ctagacttgg tggcttcata tttctatcat aatccctggg 
1001 ggtaagaaat catatagtcc caaggttggg aagggggaaa acgggttgaa 
1051 aantcctccn ccttgtagga ggcgagctct gtctcactag ctatgcccct 
1101 ccatcaattc ace eta tact cagatcagaa gactgagtgt ctgaatacag 
• 1151 tatattttct aaattcctag cccctgctgg tgaatttgcc ctcccccgct 
~10350 
1201 cctttganaa ttgtccccgt gttcgtctcc gggccctgag actggccctg 
~10010 
1251 cttatcttgc tgaccttcat cctctgctgg acaccttatt acctactggg 
1301 tatgtggtac tggttctccc ccaccatgct aactgaagtc cctcccagcc 
1351 tgagccacat ccttttcctc ttgggcctcc tcaatgctcc tttggatcct 
Figure 17 Genomic DNA sequence of the human type II GnRHR found in 
the data base. The gene specific primers (see Figure 18) designed to this 
sequence are underlined and printed in bold italics. • indicates the intron/ 
exon boundaries determined experimentally. 
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1401 ctcctctatg gggccttcac ccttggctgc cgaagagggc accaagaact 
~10068 
1451 tagtatagac tcttctaaag: a a g:g:g: t c t g:g: g:ag:aatg:ctc caagaggaga 
1501 ttcatgcctt tagacagctg gaagtacaaa aaactgtgac atcaagaagg 
1551 gcaggagaaa caaaaggcat ttctataaca tctatctgat cctaacagag 
1601 tatgtaggaa cagaatagta agtctttagt gccataagat cttaacatct 
~10071 
1651 cacttctact cctg:ctctcc 
Figure 17 ( continued). Genomic DNA sequence of the human type II 
GnRHR found in the data base. The gene specific primers (see figure 18) 





IC3 TM6 EC3 TM7 3 'UTR 
__ e_xo_n_2 __ :l .-•i•nt•ro•n•2--*•l .... ____ ex_o_n_3 ____ ____. 
10242 10349 10063 10069 10071 
4- 10070 4- 10068 
Figure 18 Diagram indicating the location of gene specific primers 
designed to the human type II GnRH receptor sequence found in the 
data base. TM - transmembrane domain, EC - extracellular loop, IC -
intracellular loop, UTR - untranslated region. Note the precise exon 




4.2 Detection and sequencing of intron-less processed RNA of part of human type II 
GnRHR 
From the type II GnRHR DNA sequence in the database, it was clear that the open reading 
frame for putative exons 2 and 3 was interrupted by an intron. However, the precise location 
of the exon/intrnn boundaries could not be deduced just from the sequence. Several possible 
intron/exon splice junctions were possible as predicted from the DNA sequence. 
To determine where RNA for the type II GnRHR is expressed, PCR was performed on 
cDNA's with gene specific primers (10417 + 10070) designed across the intron/exon boundary 
of the human type II GnRHR sequence found in the database. Using primers 10417 + 10070, 
intron-containing RNA would result in a band of 660 bp, while RNA in which the intron was 
removed or processed, would result in smaller products (Figure 19). Since we did not know 
the position of the putative exon 2/exon 3 boundary, the exact size of the processed RNA 
PCR product could not be predicted at this stage. This strategy is based on the assumption 
that the gene structure of the type II GnRHR is the same as that of the type I GnRHR. 
cDNA from several different human tissues and cell lines was obtained from R.P. Millar at 
Zymogenetics Inc., Seattle. In addition, cDNA was also prepared from various different 
human tissues by J.P. Hapgood and E. Hutchinson (Section 9, Materials and Methods). In 
total, RNA was analysed from the following cell lines and tissues: T47D (breast carcinoma), 
prostate, bone marrow, uterus, hvvec 2 (umbilical cord), testis, retina, insulinoma, MCF-7 
(breast carcinoma), fetal brain, thyroid, lymphnode, spleen, placenta, daudi (B lymphoma), 
small intestine, kidney, HUH-7, adult brain, CaC02 (colon tumor), liver, pons, medulla, 
midbrain, pituitary, hypothalamus, pBMcl, and lung. 
PCR products were separated on agarose gels and stained with EtBr (Figure 20). The result 
showed that unprocessed intron-containing RNA ( 660 bp) is present in almost all adult human 
tissues and cell lines examined, as well as fetal tissue. For some of the samples, bands of 
molecular weight lower than 660 bp were also observed, raising the possibility that some 
processed RNA had been amplified. In order to positively identify type II GnRHR PCR 
products, the PCR products were subjected to Southern blotting, probing the membrane with 
Unprocessed RNA: 
PCR band =660 bp 
Processed RNA: 






I. intron 2 
(430 bp) 
10350 
<t--- <t--- 10070 
JC3 TM6 EC3 TM7 3'UTR 








1C3 TM6 EC3 TM7 3'UTR 
exon 3 
63 
Figure 19 Schematic illustrating the rationale used to distinguish between unprocessed and 
processed (intron-less) RNA transcript by PCR with primers 10417 + 10070. Note the 
precise exon 2/exon 3 boundary (marked with *) could not be predicted at this stage. 
an internally nested primer, 10350. Positive signals at 660 bp were obtained for almost all 
the samples. On close examination of the Southern, a minor band of 200 - 300 bp was 
detected for the PCR reaction on testes cDNA, which would be consistent with the presence 


















M 13 14 15 16 17 18 192021 22 23 
_ 660bp 
_660bp 
Figure 20 PCR was performed on different 
human tissues and cell lines with primer pair 
10417 + 10070 designed across the intron/exon 
boundary of the human type II GnRHR 
sequence found in the database. PCR samples 
were run on 1 %agarose gels. The result 
showed that unprocessed intron-containing 
RNA (660 bp) is present in almost all of the 
human tissues and cell lines examined. For 
some of the samples, bands of <660 bp were 
also observed. The 660 bp bands obtained are 
marked on the figure. 1 kb ladder was used as 
a size marker (lane M). 
A: (I) Cerebellum (2) adrenal (3) testes (4) lung (5) 
cortex 
B: (1) T47D (2) prostate (3) bone marrow (4) uterus 
(5) hvvec2 (6) no sample (7) retina (8) insulinoma 
(9) MCF-7 (10) fetal brain (11) thyroid (12) 
lymphnode 
C: (13) spleen (14) placenta (15) daudi (16) small 
intestine (17) kidney (18) HUH-7 (19) adult brain 
(20) CaC02 (21) liver (22) uterus (23) liver 
A: Minigel B+C: Midi gels (Section I, Materials and Methods) 
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660 bp 
200 - 300 bp 
I 2 3 4 5 6 7 8 9 IO 11 12 
-- 660 bp 
13 14 1516 17 18 19 20 21 22 23 
- -- 660 bp 
Figure 21 Autoradiographs of Southern 
blots performed on the gels in figure 20. 
PCR was performed on various human 
tissues and cell lines with primer pair 
10417 + 10070 (Figure 20). Southern 
blots were performed on these gels, 
probing the membranes with an internally 
nested primer, 10350 (see figure 19). 
The result shows that unprocessed intron 
containing RNA ( 660 bp) is present in 
almost all adult human tissues and cell 
lines examined, as well as fetal tissue. A 
minor band of 200 - 300 bp was detected 
in human testes. Lanes as for Figure 20. 
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Attempts were made to isolate and clone the 200 - 300 bp DNA band which showed positive 
on the Southern (Figure 21 ). Because the resolution of the Southern blot was only ± 50 bp, 
we were not sure of the exact size of the positive PCR product. In addition, several DNA 
bands< 660 bp were visible on the EtBr-stained gel, and some were very faint. To obtain 
more DNA of the correct product for cloning, the region of the band was isolated from low 
melting point agarose, and reamplified with primers 10417 + 10070. Following this second 
PCR reaction, a smear of DNA bands of 200 - 300 bp was again visible by EtBr staining on 
an agarose gel (Figure 22). Southern blotting of this gel and probing with the internal primer 
10350 confirmed that the reamplified DNA still contained a DNA product of 200 - 300 bp 
containing type II GnRHR sequences (data not shown). The DNA bands from 200 - 300 bp 
were isolated by electrophoresis on a low melting point agarose gel. The DNA was isolated, 
cloned into a vector, and transformed into bacteria. Several colonies were picked and 
analysed by PCR (see Methods, section 7) to check the size of the inserts (Figure 23). Note 
that the actual size of the inserts in Figure 23 is 140 bp smaller than the bands on the gel due 
to amplification of part of the pMOS vector using this method. The clones contained several 
inserts in the range of 200 to 400 bp. Southern blotting of this gel revealed that several of 
the clones contained a DNA insert of 230 bp which contained type II GnRHR sequences ( data 
not shown). Plasmid preparations were performed on some of these colonies (eg. number 13), 
and the DNA was sequenced. The sequencing data revealed that the 230 bp fragment 
contained DNA amplified from an intron-less processed RNA of putative type II GnRHR, and 
contained exon 3 and part of exon 2 (Figure 24). 
The finding that RNA for type II GnRHR, without putative intron 2, was expressed in testes 
tissue as a minor product in the presence of excess unprocessed intron-containing RNA, and 
that most of the tissues examined appeared to express the unprocessed intron-containing RNA 
for the type II GnRHR, raised the possibility that other tissues also express the processed 
RNA. To test this possibility, PCR primers which span the exon 2 exon 3 boundary were 
designed (i.e. JHE2E3A and JHE2E3S). These primers should selectively amplify processed 
RNA and provide a more sensitive method of analysis. The primers should not anneal very 
efficiently to the intron-containing RNA, since the 3 'end of the primer would not base pair 
to the intron (Figure 24). 
101 8 hp 
506 bp 
344bp 





Figure 22 The gel-purified DNA products 
of 200 - 300 bp visible in Figure 20 were 
reamplified with primer pair 10417 + 10070, 
and checked by electrophoresis on a 1 % 
EtBr-stained agarose gel. Lanes 1 & 2 are 
testes products, and lanes 3 & 4 are pituitary 
products. 123 bp ladder was used as a 
molecular weight marker (lane M). 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
_ 200-300bp 
Figure 23 EtBr-stained agarose gel of PCR performed on clones in pMOS 
with poly linker primers T7 and Ul 9 to check the insert sizes of the colonies. 
Lanes 1 to 15 correspond to the colony numbers. The line on the right side 
indicates the actual size of the inserts cloned, and not the size of the PCR 
product. Note that the actual sizes of the inserts are 140 bp smaller than the 
bands on the gel due to amplification of part of the pMOS vector using this 













715 -----+---------+---------+---------+---------+---------+---- 774 
cgttctctggtggatattggagaagtggaagacgacggagaaagacgacggtgactgacg 
A R D H 
Q E T T 
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835 -----+---------+---------+---------+---------+---------+---- 894 
ctcggtacggggacgaccacttaaacgggagggggcgaggaaactgttaacaggggcaca 
+--E2E3A 
E P C P C W * 
S H A P A G 
A M P L L V 
I C P 
E F A L 
N L P S 
P P L L * Q 
P R S F D N 
P A P L T I 
L S P C 
C P R V 
V P V F -
tcgtctccgggccctgagactggccctgcttatcttgctgaccttcatcctctgctggac 
895 -----+---------+---------+---------+---------+---------+---- 954 
agcagaggcccgggactctgaccgggacgaatagaacgactggaagtaggagacgacctg 
..- 10070 
a S S P G P E T G P A Y L A D L H P L L D 
b R L R A L R L A L L I L L T F I L C W T 







Figure 24 DNA sequence and protein translation of the processed human type II GnRHR 
from 10417 to 10070. Frame b corresponds to the correct frame. The sequence of the 
primers is underlined. The sequence was obtained by sequencing 3 independent clones. 
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To check for the presence of processed transcript m our available cDNA's, PCR was 
performed with primers IBE2E3A and 10417 (located in EC2 in exon 2). Processed RNA 
would thus amplify a PCR product of 144 bp, which is 430 bp (size of intron 2) smaller 
than that obtained for unprocessed RNA (Figure 25). PCR was performed on the available 
human cDNA's from a total of 28 different human tissues and cell lines. The results showed 
the presence of a -130 bp product in almost all the cDNAs, which is indicative of the absence 
of an intron (Figure 26). The products were also checked by Southern blotting, probing the 
membrane with an internally nested oligo (10349) (Figure 27). The size of positives on the 
autoradiograph was consistent with the size of major bands seen on the EtBr-stained agarose 
gel at 130 bp. In appears from Southern blotting that the expression levels of T47D, fetal 
brain, placental, pituitary, and testis is high, and that the kidney has a very low signal. 
However, no accurate quantification of relative levels of expression can be deduced from this 
PCR reaction. 
To confirm our results showing the presence of processed RNA, the PCR was repeated with 
a different set of primers, i.e. IBE2E3S and 10068 (located in TM7 in exon 3) (Figure 25). 
PCR was repeated on all 40 different cDNA samples. The products were checked by agarose 
gel electrophoresis (Figure 28), as well as by Southern blotting, probing the membrane with 
an internally nested oligo (I0350)(Figure 29). The sizes of the positives on the 
autoradiograph were consistent with the size of major bands seen on the EtBr-stained agarose 
gel at 350 bp, confirming the presence of processed intron-less RNA for the human type II 
GnRHR in almost all human tissues tested. Although this strategy did confirm the presence 




PCR band: 10417 + E2E3A 







EC2 TM5 1C3 TM6 EC3 TM7 3'UTR 
exon 2 exon 3 
intron 2 
(430 bp) --tJHE2E3S 
~ JHE2E3A 
10417 10349 10350 10068 
--+ --+ +- 4--
EC2 TM5 1C3 TM6 EC3 TM7 3'UTR 
exon 2 exon 3 
70 
Figure 25 Schematic illustrating the PCR strategy used to selectively amplify intron-less 
RNA, by use of PCR primers (JHE2E3S & JHE2E3A) designed across the exon2/exon3 
boundary determined for the human type II GnRHR. This strategy did not distinguish 
between "sense" and "antisense" RNA transcripts. PCR band expected with 10417 + 
JHE2E3A = 144 bp, and JHE2E3S + 10068 = 337 bp for processed (intron-less) type II 
GnRHR cDNA. No PCR band was expected for unprocessed intron-containing cDNA (3' 









M I 2 3 4 5 6 7 8 9 10 11 12 13 
_ 1301,p 
M 14 15 16 11 18 19 20 21 22 23 
_ 1301,p 
M 24 2s 26 272829 303132333435 36373839 4041 
- 1301,p 
Figure 26 EtBr-stained agarose gel of PCR 
performed on various human cDNA's with 
primer pair JHE2E3A and 10417. The 130 bp 
band of the expected size that was obtained is 
marked on the figure. 1 kb ladder was used as 
a size marker (lane M). In some of the 
samples the 130 bp band is not visible in the 
photograph, but was faintly visible by eye. 
( 1) T 4 7D (2) prostate (3) bone marrow ( 4) uterus ( 5) hvvec 
2 (6) testes (7) retina (8) insulinoma (9) MCF-7 (10) fetal 
brain (11) thyroid (12) lymphnode (13) spleen (14) 
placenta (15) daudi (16) small intestine (17) kidney (18) 
HUH-7 (19) adult brain (20) CaC02 (21) liver (22) uterus 
(23) positive control (10417/10070 cloned cDNA) (24) 
pons (25) pons (26) pons (27) pons (28) medulla (29) 
medulla (30) medulla (31) mid brain (32) mid brain (33) 
midbrain (34) pituitary (35) hypothalamus (36) pBMcl 




14 15 16 17 18 19 20 21 22 23 
_ I30 bp 
24 2526 2728 293031 3233 34 35 363738 3940 41 
-130"" 
Figure 27 Autoradiographs of Southern 
blots performed on the gels in Figure 26, 
probing with 10349. The presence of a band 
of 130 bp containing part of processed 
intron-less type II GnRHR cDNA in various 
human tissues is marked on the figure. 









M21222425 26 27 282930313233 343536 37383940 41 
-- 350bp 
-- 350bp 
Figure 28 Products of PCR performed on human 
cDNA's with primer pair JHE2E3S + 10068 were 
checked on a 1.5 % EtBr-stained agarose gel. A very 
clear -350 bp band, indicated by arrows, is visible in 
almost all of the human tissues and cell lines tested, 
indicating the presence of "processed" intron-less 
cDNA. 1 kb ladder was used as a size marker (lane 
M). 
(1) T47D (2) prostate (3) bone marrow (4) uterus (5) hvvec2 (6) 
testes (7) retina (8) insulinoma (9) MCF-7 (I 0) fetal brain (11) 
thyroid (12) lymphnode (13) spleen (14) placenta (15) daudi (16) 
small intestine (17) kidney (18) HUH-7 (19) adult brain (20) CaC02 
(21) liver (22) uterus (24) pons (25) pons (26) pons (27) pons (28) 
medulla (29) medulla (30) medulla (31) midbrain (32) midbrain (33) 
midbrain (34) pituitary (35) hypothalamus (36) pBMcl (37) testes 
(38) hypothalamus (39) liver (40) pituitary (41) lung. 
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I 2 3 4 5 6 7 8 9 IO II 12 13 14 15 16 17 18 19 20 
-- 350bp 
-- 350bp 
2122 242526272829 3031323334 35 36373839 40 41 
Figure 29 Autoradiograph of a Southern blot 
performed on the gel in Figure 28. The 
membrane was probed with 10350. The lines 
indicate the presence of a positive signal at 350 
bp, confirming the presence of processed intron-
less cDNA for the human type II GnRHR in 




4.3 Generation of a testes cDNA clone containing type II human GnRHR from 10417 
to 10071 
PCR was performed on human testes cDNA with primer pair 10351 and 10071 to isolate a 
fragment containing sequences which overlapped on the 3' end with the fragment obtained 
from 10417 + 10070. The two fragments were then joined by use of restriction enzymes. 
This fragment was prepared in order to construct a full length cDNA. We now had a clone 
that contained part of putative exon 2 and putative exon 3 of a possible type II GnRHR gene, 
but lacking putative exon 1. Attempts to obtain exon 1 are described below. 
4.4 Attempts to obtain exon 1 of human type II GnRHR cDNA 
Additional data base searches with exon 2 sequences did not reveal any exon I-like sequences 
for the type II GnRHR (J.P. Hapgood, personal communication). It was decided to perform 
5'RACE in order to try and clone the full length receptor. The primer JHE2E3A (see section 
4.2) was exploited in our strategy. 
Different strategies were followed, to ensure that we had as many options as possible for 
cloning the full-length receptor. cDNA was prepared using several different RNA priming 
methods, i.e. priming with gene specific primers, random priming, and dT priming. The 
5'RACE was performed on cDNA's from several tissues, based on the results of section 4.2. 
Two different 5'RACE methods were used, namely 5'RACE using the Gibco BRL Kit (Figure 
30), and Marathon 5'RACE (Clontech Kit). Marathon RACE reactions are capable of 
amplifying much larger templates than can be amplified with conventional RACE methods, 
since the protocol uses enzyme mixes designed for long distance PCR (LD PCR). The 
marathon RACE reaction uses a combination of proofreading and non-proofreading Taq 
polymerases designed to obtain high fidelity PCR. Also, Taq Start Antibody provides an 
automatic form of hot start PCR. The essential features of the two different RACE methods 
are summarized in Figure 31. Where possible, we often reamplified the original PCR 
products with internally nested gene specific primers, ensuring that the products we amplified 
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GSPl , to mRNA 
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with RNase H 
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dCTP and TdT 
Amplify dC-tailed cDNA by PCR 
using the Anchor Primer and nested 
GSP2 
Figure 30 Overview of the Gibco BRL S'RACE Protocol. 




5'RACE using Gibco BRL Kit Marathon 5'RACE 
• Uses single-stranded cDNA • Uses double-stranded cDNA 
synthesis (dT primed) 
(We tried priming with GSPs, 
random priming, and dT priming) 
• dC-tailed (3') with TdT • Adaptor ligation 
(T4 DNA ligase) 
• Amplifies target cDNA with • Amplifies target cDNA with 
anchor primer (sense) and adaptor primer containing dTs 
GSP ( antisense) and GSPs 
Figure 31 Summary of the essential features of the two 5'RACE methods. GSP = gene 
specific primer. 
We performed marathon 5'RACE with the JHE2E3A primer (designed across the putative 
exon 2/exon 3 boundary), in order to selectively amplify intron-less cDNA in the presence of 
an excess of intron-containing cDNA's. Marathon 5'RACE on testes cDNA produced a 
fragment of -3.5 kb visible by EtBr-staining on an analytical agarose gel (Figure 32). 
Southern blotting with an internally nested oligo (10242) produced a signal consistent with 
the size of the major band seen on the analytical gel at -3.5 kb (Figure 33). This fragment 
was isolated by electrophoresis on a low melting point agarose gel excision and elution (See 
section 5, Materials and Methods). After purification, the DNA fragment was reamplified 
with different combinations of internally nested oligo's, i.e. APl + JHE2E3A, APl + JHE2, 
AP2 + JHE2E3A, and AP2 + JHE2 (AP= Marathon adaptor primer). Upon analysis on an 




M 1 2 3 4 5 6 7 8 9 10 111213 1415 16 17 
_ 3.5kb 
Figure 32 EtBr-stained agarose gel of the products of marathon 5'RACE 
performed with JHE2E3A. A faint 3.5 kb band (indicated by line) is visible for 
testes. 1 kb ladder was used as a size marker (lane M). 
(1) - (9) Testes cDNA (different preparations), (10) T47D, (11) testes, (12) MCF-7, (13) fetal brain, 
(14) thyroid, (15) placenta, (16) daudi, (17) lymphnode 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
3.Skb __ 
. 
Figure 33 Autoradiograph of a Southern blot performed on the gel 
in Figure 32. The membrane was probed with 10242. A clear 
signal can be detected at - 3.5 kb for testes, as well as for some of 
the other samples. 
(1) - (9) Testes (different preparations), (10) T47D, (11) testes, (12) MCF-7, (13) 







M 1 2 3 4 
-- 2.5kb 
Figure 34 Reamplification of the 3.5 kb fragment 
visible in Figure 32 with 
(1) API + JHE2E3A 
(2) API + JHE2 
(3) AP2 + JHE2E3A 
. (4) AP2 + JHE2. 
A clear band of -2.5 kb (indicated by line) is 
visible by EtBr-staining of the agarose gel. 1 kb 
ladder was used as a size marker (lane M). 
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This led us to suspect that the 3.5 kb band visible on the Southern blot was a minor 
component of the 3.5 kb PCR product detected by EtBr staining. We therefore attempted to 
isolate the minor 3.5 kb PCR product by analysing several clones obtained by cloning DNA 
PCR products in the region of the 3.5 kb band isolated from low melting point agarose. 
Different methods were used for analysis of the colonies, namely: 
a) Direct PCR screening of colonies with primers located in the vector, followed by Southern 
blotting, probing with an internally nested oligo. 
b) Colony blots, probing with an internally nested oligo. This method allows us to probe a 
great many colonies at once. In excess of 150 colonies were screened by this method. 
No positive colonies were detected in any of the Southern blots performed. 
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Additional primer pairs were tried in the 5'RACE reaction, i.e. first reaction with 10350 and 
adaptor primer, followed by nested PCR with JHE2E3A and adaptor primer, using the 
marathon RACE kit. cDNA from testes was used as template. Electrophoresis on an agarose 
gel and staining with EtBr revealed a faint 1.6 kb PCR product on the second reaction ( data 
not shown). Southern blotting, probing with an internally nested oligo (10242) produced a 
strong signal corresponding to the band detected on the gel at 1.6 kb (Figure 35). The 
fragment was isolated by electrophoresis on a low melting point agarose gel, followed by 
purification of the fragment from the agarose (See section 5.2, Materials and Methods). After 
cloning into pMOS and PCR screening of colonies (Section 7, Materials and Methods), a 
Southern blot was performed, probing with an oligo designed to putative intron 2 sequences 
lA 2A 3A 4A 5A IB 2B 3B 4B 5B 
- 1.6kb 
Figure 35 PCR was performed on testes cDNA with 
APl + 10350 (A). A second reaction was performed 
with internally nested primers AP2 + JHE2E3A (B). 
The figure shows an autoradiograph of a Southern blot 
performed on the EtBr-stained agarose gel, probing 
with internally nested oligo 10242. A strong signal 
(marked on the figure) corresponding to 1.6 kb, is 
visible. Lanes 2A to 5A, and 2B to 5B shows the 
result of reactions of different batches of testes cDNA, 
and lanes IA and lB shows the results of reactions of 
T47D cells (see section 4.5) 
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(JHi2S). No positive signals were detected on the autoradiograph, indicating that the 1.6 kb 
fragment did not contain any intron 2 sequences (data not shown). 
In order to obtain sufficient DNA of the 1.6 kb fragment for cloning, the gel-purified 
fragment was reamplified with internally nested oligo's (AP2 + JHE2E3A, or AP2 + JHE2). 
This produced very clear bands of - 1.6 kb on an EtBr-stained analytical agarose gel (Figure 
36). The 1.6 kb fragments were isolated from low melting point agarose gels, cloned into a 
vector, and transformed into bacteria. Analysis of the clones by colony PCR screening, 
followed by Southern blot, probing with an internally nested oligo (JHE2) produced a very 
strong signal at 1.6 kb for several of the clones, corresponding to the size of the fragments 
detected on the agarose gel ( data not shown). Positive colonies on Southern blots were 
subjected to plasmid preparations to obtain sufficient DNA for analysis by DNA sequencing. 
Figure 37 shows the sequence of the full length 1.6 kb 5'RACE product. The sequence was 
confirmed by sequencing several individual clones, in both directions, with several different 
primers. The sequencing results showed that the open reading frame 5' to putative exon 2 
is not in frame with the open reading frame in putative exon 2, and a stop site occurs between 
the two open reading frames. The open reading frame 5' to putative exon 2 has no similarity 
to exon 1 of the human type I GnRHR, or to any other known receptor or protein. The 
sequencing data was analysed by doing homology searches on data bases on both the amino 
acid level, and the DNA level. 
Figure 36 Reamplificatio 
of the 1.6 kb band visible i 
Figure 35 with primer pair 
(1) AP2 + JHE2E3A, and (2) 
AP2 + JHE2 produced ver 2 kb clear bands of - 1.6 kb on 
EtBr-stained agarose gel, a 1. 6 kb 
indicated by the line. 1 k 
ladder was used 1 kb 
molecular weight 
(lane M). 





















1 ---------+---------+---------+---------+---------+---------+ 60 
TGAGTGATATCCCGAGCTCGCCGGCGGGCCCGTCCACCTTTAACTAGTAATGACATTTGT 
T H Y 
L T I 
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L L * T 
Y C K H 
T V N I -
TAGTGAGGAGATTAAAGACAACTGTAGAAACTGGAAGCCAACATGTGATGTTTTTCGTAA 
82 
61 ---------+---------+---------+---------+---------+---------+ 120 
ATCACTCCTCTAATTTCTGTTGACATCTTTGACCTTCGGTTGTACACTACAAAAAGCATT 
* * D * L * K L 
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R S F 
K E V L 
K K F * 
E A V 
K Q y 
S S T 
p T 
Q L 
N * N -
ATACTCAGAAACACCCTTTTCACGTGAATATTATGAGAAGAAAAGAGAACATGAAGAAAT 
241 ---------+---------+---------+---------+---------+---------+ 300 
TATGAGTCTTTGTGGGAAAAGTGCACTTATAATACTCTTCTTTTCTCTTGTACTTCTTTA 
I L R N T L F T * I L * 
Y S E T P F S R E Y Y 
T Q K H P F H V N I M 
E E K R T * 
E K K R E H 
R R K E N M 
R N 
E E I 
K K F -
TCAAAGCAGAGTGTTGGCATGTACTGAACAATTAAAAATGAATGAAACAATTTTTATGAA 
301 ---------+---------+---------+---------+---------+---------+ 360 
AGTTTCGTCTCACAACCGTACATGACTTGTTAATTTTTACTTACTTTGTTAAAAATACTT 
S K Q S V G M Y * T I K N E * N N F Y E 
Q S R V L A C T E Q L K M N E T I F M K 
Figure 37 DNA and amino acid sequence of the full length 1.6 kb 5'RACE product from 
testes (visible in Figure 36). The position of the primers used in the 5'RACE reactions are 
indicated in bold and by solid lines. The positions of putative extracellular loop 2 (EC2), 
transmembrane domain 5 (TM5), and intracellular loop 3 (IC3) are marked (see pages 82 + 

























361 ---------+---------+---------+---------+---------+---------+ 420 
TAAAGCTCACGGACGAGGGAAAGGTAGTGAATGATTTACCTGAAATTTGTAACAATTAAA 
I S S A C S L S I T Y * M D F K H C * F 
F R V P A P F P S L T K W T L N I V N L 
F E C L L P F H H L L N G L * T L L I * -
GAGATGTGAAACACAAGATATTCTTAAACATGCCAGCAATCTTACCAAAAGTTCATCCGA 






































481 ---------+---------+---------+---------+---------+---------+ 540 
TAACTTCTTTCTTCATCTACTTTACCTTTATCTTTAATTAATAAATTTGGTCTATAGATC 
I E E R S R * 
L K K E V D 
* R K K * M 
N G N 
E M E I 
K W K * 
R N * 
E I N 







K P D I 
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541 ---------+---------+---------+---------+---------+---------+ 600 
CGTATTACTTTGATTCCGAGAAAGTCTTTGAGACCTTCTTTTCTTGTTTTTATGTCTTTT 
A * * 
N 
Y R K 





G S F R N S G R K E Q K 
K A L S E T L E E K N K N 
R L F Q K L W K K R T K I Q K T -
CAGAAAAGAACTGAAAGAAAGAATTTTTGGAAAAGATGAGCATGTACTTACATTGAATAA 
601 ---------+---------+---------+---------+----- - ---+----- - ---+ 660 
GTCTTTTCTTGACTTTCTTTCTTAAAAACCTTTTCTACTCGTACATGAATGTAACTTATT 
Q K R T 
R K E L 
E K N * 
E R K N F W K R * 
K E R I F G K D 
K K E F L E K M 
A C T Y I 
E H V L T L 














































































































































781 ---------+---------+---------+---------+---------+---------+ 840 
TTTCGAACGGTTATAACTGAAATCTGTTTTTCTTTTACTATGTGTCTATAAATTACTGAG 
K A C Q Y * L * T K R K * Y T D I * * L 
K L A N I D F R Q K E N D T Q I F N D S 
S L P I L T L D K K K M I H R Y L M T L -
TGCTGTGGATAACCATTCAAAATGTTCACATATTACGACTATCACAAGGTCACAAAAGTT 






























































901 ---------+---------+---------+---------+---------+---------+ 960 
ATACGTTCAGTCTAACAATTGGGGTGTCTTTGTTAGTTTAAGGTTAGTCACCAGCCTTTT 
Y A S 
M Q V 























S V V G K 
Q W S E K 
S G R K K -
AGGGGATAAAGATGCTGAGTATGGAGATAAAGGGACAGTAAGACAAGTAAGAGAATCAAA 
84 
961 ---------+---------+---------+---------+---------+---------+ 1020 
TCCCCTATTTCTACGACTCATACCTCTATTTCCCTGTCATTCTGTTCATTCTCTTAGTTT 
R G * K T S K R I K 
R E S K G D 
G I 
* R C * 
K D A 
K M L 
V W R 
E Y G D 
S M E I 
R D S 
K G T V 
K G Q * 
R Q V 
D K * E N Q N -
ATGTACTTCACAAGCTATATATACTGAACATTTTGGGAAGTCAATAGAAAATGTAGTGAT 







F T S Y 
S Q A I 











F W E 
F G K 
















1081 ---------+------ ---+---------+---------+--- ------+---------+ 1140 
CTTCATCTTCTCTCTCGACTCTTAAAAGGTGCTTGCAGACTTTAAGGATATAAAAATCTT 
E V E E R A E N F P R T S E I P I 
K * K R E L R I F H E R L K F L Y 
S R R E S * E F S T N V * N S Y I 
F L E 
F * N 
F R I -
JHE1S~ 
TCCCAAAGCTGTGAAAGCACCTGAGTCATTGGAGAAAATAAAATTCCCTAAAACCCCCCC 
1141 ---------+---------+---------+---------+---------+- - -------+ 1200 
AGGGTTTCGACACTTTCGTGGACTCAGTAACCTCTTTTATTTTAAGGGATTTTGGGGGGG 
S Q S C 
P K A V 
P K L * 
E S T * V I G E N 
K A P E S L E K I 
K H L S H W R K 
K I P * 
K F P 
* N S L 
N p p 
K T P P 



















































R K G 
E K E 








1261 ---------+---------+---------+---------+---------+---------+ 1320 
ACCTGAAAGAAAAGAATACTCAATATGAAGATCTAGTGGACCTAACTTAAATAAACTAAG 
W T F F S Y 
G L S F L M 










I T W 
S P G 

















1321 ---------+---------+---------+---------+---------+---------+ 1380 
AAGACATAAACTATGTCTTTAGAGTAGTCTAGTCAAATTACTTGTAATAAGACGTTCTTT 
F C I 
S V 
L y 
* Y R N L 
F D T E I S 


















C K K 
A R N 
L Q E I -
TCTAAATCCTCTGTCATCAGAGCAAGAGATTGAAAAGACCAAGTGTTTTCAGAATGAGGG 

















A R D 
Q E I 
K R L 
* K D Q V F 
E K T K C 










1441 ---------+---------+---------+---------+---------+---------+ 1500 
CTTTTTTCCAGTAGTACTCGATCTTTTGGACCCTTCCTAAGTGGCTTCTCGACAAGGACA 
E K R S S * A 
K K G H H E L 
K K V I M S * 
R K P G K D 
E N L G R 
K T W E G 
I 
S P K S C S 
H R R A V 














s T p s T E L A Q s L s L s V s p K A A 
p H R p L s w p s p F H s V C H Q R Q L 










































































C H * L P W S 
A T D C H G H 
P L T A M V I 
+-JHE2E3A 
S A I A A L S 
L L * P H C P 
C Y S R I V L 
AGACAAGGAAGGGGAGCCATGCCCCTGCTG 
1681 ---------+---------+---------+ 1710 
TCTGTTCCTTCCCCTCGGTACGGGGACGAC 
a R Q G R G A M P L L 
b D K E G E P C P C W 
c T R K G S H A P A G -
S V C P A P 
Q C V Q P P 
S V S S P Q -
--------IC3-------
4.5 Attempts to clone the full-length receptor from tissues other than testes 
5'RACE, using the Marathon kit, was performed with primer pair JHE2E3A + APl on cDNA 
from tissues other than testes, i.e. T47D, MCF-7, fetal brain, thyroid, placenta, daudi, and 
lymphnode. As found for testes (see section 4.4, Figure 33), a 3.5 kb band was also detected 
by Southern blotting, probing with 10242 (Figure 38). A strong signal was also detected at 
1.6 kb in the T47D sample. Since attempts to clone the 3.5 kb testes fragment were 
unsuccessful, we decided to attempt to clone the 1.6 kb fragment detected in T47D. The 
fragment was isolated by electrophoresis on low melting point agarose, followed by 
purification of the DNA from the agarose. The 1.6 kb fragment was cloned into a vector, and 
transformed into bacteria. The colonies were analysed by colony PCR screening, followed 
by agarose gel electrophoresis with molecular weight markers. Bands on the EtBr-stained 
agarose gel corresponded with the expected size (i.e. 1.6 kb) of the insert (Figure 39). A 
Southern blot was performed on this gel, probing the membrane with an internally nested 
oligo (10242). No positive signals were detected on the autoradiograph (data not shown). 
Reamplification of the product isolated from the agarose gel also did not produce the expected 
results. To confirm that none of the colonies did contain the full-length receptor cDNA, 
colonies were screened by colony Southern blotting, allowing us to screen in excess of 150 
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colonies at once. Once again no positives were detected on the autoradiographs. We then 




3.5 - 4 kb 
1.6 kb 
1234 5 6 78 
Figure 38 5'RACE was performed on different 
human tissues and cell lines with AP 1 + JHE2E3A, 
followed by Southern blotting with 10242. A clear 
3.5 kb band is visible in all the samples, but only 
T47D shows a 1.6 kb signal. Note that the particular 
testes RNA in this experiment did not show the 1.6 
kb band, unlike the result shown in Figure 35 . 
(1) T47D, (2) testes, (3) MCF-7, (4) fetal brain, (5) thyroid, (6) 
placenta, (7) daudi, (8) lymphnode. 
Ml 2 3 4 5 6 7 8 91011121314151617181920 
-- 1.6kb 
Figure 39 Colony PCR screening of 1.6 kb T47D colonies with pMOS 
polylinker primers T7 and U19. The arrow indicates the 1.6 kb band. 
Lanes 1-20 correspond to colony numbers. Lane Mis marker. 
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5. ANALYSIS OF GENOMIC CLONES FOR HUMAN TYPE II GnRH 
RECEPTOR 
Pl clones containing human genomic DNA inserts of-70 kb were purchased from Genome 
Systems Inc. These were obtained by screening a human genomic DNA library with a PCR 
product generated with 10417 + 10070, i.e. putative exon 2/intron 2/exon 3 sequences. Three 
clones were obtained, i.e. PIA, PIB, and PIC. 
The rationale for using these genomic clones was twofold: 
a) To confirm that the type II GnRHR cDNA we cloned does exist in the human genome and 
is thus not an artifact. 
b) It provided us with an alternative strategy to obtain exon 1 of the type II human GnRHR. 
a) In an initial analysis of the genomic clones, we wanted to confirm the presence of putative 
exon 2/intron 2/exon 3 sequences found in the data base and in our cDNA sequences (minus 
intron). PCR was performed on clones PIA, PIB, and PlC with different combinations of 
gene specific primers ( designed to the sequence found in the data base) for confirmation of 
the presence of exons 2 and 3. These primer pairs are 10063 + 10068 (IC 3 to TM 7), 10349 
+ 10070 (TM 5 to IC 3), and 10349 + 10068 (TM 5 to TM 7). Agarose gel electrophoresis 
(Figure 40) and Southern blotting (Figure 41) confirmed that the sequences isolated from 
cDNA containing exon 2 and exon 3 from TM 5 to TM 7 are present in the genomic DNA. 
b) To look for the presence of exon 1, PCR was performed with different combinations of 
degenerate primers designed to the type I human GnRH receptor. These were 1 S + 2A 
(designed to amplify TMl - TM2), lS + 3A (TMl - TM3), and lS + 10607 (TMl -TM2) 
Agarose gel electrophoresis and Southern blotting confirmed that none of the primer pairs 
amplified a fragment indicative of exon 1. The positive controls (human genomic DNA) 
showed bands of the expected size on EtBr-stained agarose gels, indicating that the conditions 
used for the PCR reactions were specific enough to amplify exon 1 of the human type I 
GnRHR if it were present. 
89 
PCR was performed on the genomic clones with gene specific primers designed to the cloned 
1.6 kb 5' RACE testes product 5' to exon 2 (see section 4.4), i.e. putative exon 1 sequences. 
Our intent was to see if the 5' RACE sequences 5' to exon 2 occurs in the genomic clone 5' 
to exon 2. If this occurred, we could be reasonably sure that the 5'RACE product was 
authentic. Five different combinations of primers were used, i.e. JHE1S3 + lliElA, n-IE1S3 
+ 10242, n-IE1S3 + n-IE1A2, 10351 + 10071, and JHElS + 10242. The products were 
checked by electrophoresis on an agarose gel , as well as by Southern blotting, probing the 
membrane with an internally nested oligo. No positive signals were obtained on the 
autoradiographs ( data not shown), although some faint bands could be seen on EtBr-stained 
agarose gels. 





Figure 40 PCR performed on P 1 clones with gene specific primers 
confirmed the presence of putative exon 2 and 3 of the type II 
GnRHR. Human genomic DNA (lanes marked h) was included in the 
PCR experiment as a positive control. Lanes that contain the negative 
controls (no DNA) are marked (-). The lines indicate the correct 
sized bands on the gel. 
Sizes expected are: 10063 + 10068 = 230 bp; 10349 + 10070 = 330 
bp, and 10349 + 10068 = 534 bp. 
Primer pair 063 + 068 349 + 070 
Sample 
349 + 068 




Figure 41 Autoradiograph of Southern blot performed on the gel in Figure 
40 with a 10063 + 10068 PCR-generated probe (see section 2.6.3, Materials 
and Methods). The sizes of the positive signals obtained are consistent with 
the sizes of the bands indicated with lines in the EtBr-stained agarose gel. 
P 1 A, P 1 B, and P 1 C refer to the 3 different genomic clones. Lane (-) is the 
negative (no DNA) control, and lane h the positive (human genomic DNA) 
control. 
This could be as a result of a few possibilities: 
a) The genomic clones do not contain the sequences from the 5'RACE clone 5' to exon 
2, because these sequences occur further 5' to the 70 kb genomic clone. 
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b) The genomic clones do contain sequences from the 5'RACE clone 5' to exon 2, but intron 
1 might be too big to PCR across. 
c) The 1.6 kb 5'RACE product was the result of an artifactual amplification of another gene 
with the exon 2 to exon 3 region of the GnRHR gene, and the sequences 5' to exon 2 
are therefore not part of the GnRHR gene. 
In all 3 cases, the appearance of PCR products by EtBr staining would be due to non-specific 
annealing of the primers to the genomic DNA, as confirmed by the lack of positive signals 




GnRH is a central reproductive hormone in all vertebrates, and exerts its effects via binding 
to the GnRHR. This investigation was part of a larger effort to clone GnRHRs from different 
species by a PCR approach. Insights about structure-function relationships are frequently 
obtained by a comparison of conserved and non-conserved amino acids of receptors from 
different species. Prior to commencement ofthis project, only eutherian mammalian GnRHRs 
had been cloned, and no non-mammalian GnRHRs. These mammalian GnRHRs were all 
highly conserved in both the TMs and loops (see Figure 5, Introduction), and were the so-
called type I GnRHR found in the pituitary gonadotrophs and responsible for the classical 
endocrine response of LH and FSH release due to binding to mGnRH. During the course of 
this project, a second form of the GnRHR was identified in reptile and toad (Xenopus), the 
so-called type II GnRHR due to the presence of several non-conserved amino acids relative 
to the type I GnRHR. The function of this type II GnRHR is not known, but it was thought 
to be the receptor for the CII GnRH hormone involved in non-pituitary neurotransmitter 
actions. From these results, and also since mammals were recently found to contain two 
different forms of GnRH, i.e. mGnRH and CII GnRH, it was proposed that mammals also 
express a type II form of GnRHR. Therefore, in this project attempts were made to find a 
type II GnRHR in higher mammals, i.e. mouse and human. In addition, the mole was 
investigated since, as an example of a more primitive non-placental mammal, its receptor(s) 
may be particularly interesting. In addition, redbait was investigated as an example of a 
tunicate, since GnRH had been found in other tunicates, but no receptor had been identified. 
A GnRHR from an organism so far separated from mammals in evolutionary development 
would be expected to yield important structure/function information. 
The aim of this project was to clone novel GnRHRs, i.e. type I and type II GnRHRs from 
redbait and mole and type II mouse and human GnRHRs using a PCR strategy. PCR was 
performed with degenerate primers designed to human type I GnRHR to areas that are not 
conserved between GPCRs in general, but are conserved between mammalian GnRHRs. No 
positive results were obtained with any of the primer pairs tried on redbait. A fragment of 
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a novel type I mole GnRHR was obtained. This cloned fragment corresponds to exon 1 of 
the human type I GnRHR, from TM 1 to TM 2. Attempts to clone a type II GnRHR from 
mole or mouse were unsuccessful. We managed to clone a part of a novel type II GnRHR 
from human tissues. The cloned receptor corresponds to exons 2 and 3 (TM 4 to TM 7) of 
the type I human GnRHR. A 1.6 kb 5'RACE type II GnRHR product was successfully 
isolated from human testes cDNA. 
A parallel investigation by other members of the laboratory on other species has shown that 
these different primer pairs have been successful in the isolation of other non-mammalian 
GnRHR's, including the GnRHR's from Xenopus, goldfish, and chicken (unpublished). 
Primer pair 5S/6A2 has been used successfully to clone a part of type I and type II GnRHR 
from Xenopus as well as goldfish (Brigitte Troskie, personal communication). To date, only 
a type I GnRHR has been cloned from chicken (Yuh-man Sun, personal communication). 
4.1 Redbait GnRHR 
PCR was performed on redbait genomic DNA using degenerate primers designed to areas of 
the GnRH receptor that are highly conserved between different mammals. Although PCR 
products of the expected size were obtained for some of the primer pairs, as well as some 
positive signals upon analysis by Southern blotting (Chapter 3, Section 2), all attempts to 
clone a novel GnRHR from redbait gDNA failed. The positive signals were found to be due 
to contamination, possibly via plasmids in the laboratory. 
The reason this strategy did not work on redbait, might be that the redbait GnRHR differs 
substantially from that of the mammalian GnRH receptors. If the redbait GnRHR is very 
different from the other cloned receptors (in other words, if the redbait GnRHR has a very 
low homology to other GnRH receptors), PCR might not be the best method of isolating this 
receptor. If we lower the specificity of the PCR reaction too much, we would probably get 
a lot of non-specific amplification, and still not amplify the redbait GnRHR. A different 
cloning strategy would thus be necessary, for instance one that is based on expression 
screening of cDNAs with GnRH ligand. 
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Another possibility is that there is no GnRHR in redbait. However, this is very unlikely, 
since we know that GnRH has been detected in tunicates (Powell et al., 1996). The presence 
of GnRH implicates the presence of GnRHR. 
4.2 Type I GnRHR gene from mole 
Sequence analysis revealed that this fragment was indeed exon 1 of the mole type I GnRHR. 
This exon 1 type I mole GnRHR fragment is 89.5% homologous to human type I GnRHR on 
the DNA level, and 93% on the amino acid level (see Figure 16 and Figure 43). The exon 1 
fragment of the type I mole GnRHR differed from the human type I GnRHR in only 4 amino 
acids out of a total of 96. Furthermore, these were all conservative changes, i.e. V to A, A 
to T, L to V, and A to G. Also, these changes all occurred in the transmembrane domains, 
and not in the loop areas, as one would expect. Important amino acids conserved, are the 
asparigine in TM 1, since this amino acid is conserved in all known GPCRs, as well as the 
leucine in TM 2, which is conserved in most of the known GPCRs. Other conserved amino 
acids include the VMPLD sequence in TM 2, which is conserved in all the mammalian 
GnRHRs. Other amino acids that are conserved in mole, as in all the other mammalian 
GnRHRs, include R, V, T, L, N, and Lin TM 1, and three L's and Tin TM 2. 
We decided not to continue our efforts on isolating the rest of the type I GnRHR from mole 
genomic DNA, since the fragment we had isolated was very similar to the human type I 
GnRHR, and the results were unlikely to be very interesting. 
4.3 Human type II GnRHR 
Human genome data base searches performed with the sequence of a type II GnRH receptor 
from reptile, revealed the presence of antisense human type II GnRHR EST cDNA clones in 
several human tissues, showing that a gene for a type II GnRHR exists in the human genome. 
Using gene specific primers designed to this sequence, we showed that several human tissues 
and cell lines expressed intron-containing type II GnRHR RNA. PCR results which support 
this finding are unlikely to be due to genomic DNA contamination, since for several of the 
samples, poly A RNA was used as a template for cDNA synthesis. In addition, Northern blot 
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analysis of RNA from these tissues has revealed the presence of distinct RNA bands 
containing type II GnRH sequences (R.P. Millar, personal communication). The presence in 
the date base of antisense cDNA type II clones, together with our results, raises the possibility 
that antisense type II GnRHR transcripts containing an intron are widely expressed in human 
tissue. The possible biological function of such transcripts is unknown, but they could have 
a regulatory function in suppressing transcription of the sense transcript. 
We isolated a testes cDNA clone (Section 4.3, Results) containing type II human GnRHR 
from EC2 (located in exon 2) to the end of TM 7 (located in exon 3). This result shows that 
a processed RNA transcript (i.e. not containing intron) coding for part of a GnRHR, i.e. exons 
2 and 3, is indeed expressed in at least one human tissue. This processed transcript is clearly 
of much lower abundance than the intron-containing transcript. From our results we are 
unable to determine whether the processed transcript is the sense or the antisense strand. 
Using a primer designed to span the exon 2/exon 3 boundary to selectively amplify processed 
RNA rather than intron-containing RNA, we showed that several other human tissues may 
also express the processed RNA. However, this result must be interpreted with some caution, 
as it is possible that the 3 'end of the primer annealed to the one exon without the 5 'part 
annealing to the other exon. This is unlikely, as the 3'part of the primer would have to 
anneal to only 3 bp. 
Different strategies were used to attempt to obtain exon 1 of the human type II GnRHR. 
These include PCR on genomic DNA with degenerate primers designed to regions of exon 
1 of the human type I GnRHR that are highly conserved between different mammals, as well 
as 5'RACE on cDNA from various tissues. 5'RACE reactions, which exploited the use of 
the exon 2/exon 3 gene specific primer to the human type II GnRHR (JHE2E3) were 
performed, followed by Southern blotting and probing with an internally nested oligo. 
5'RACE performed on testes cDNA produced DNA fragments of 3.5 kb and 1.6 kb (see 
section 4.4). We were unable to isolate a clone containing the 3.5 kb RACE product, despite 
extensive efforts that included reamplification of the 3.5 kb fragment with internally nested 
primers, and extensive colony screening (in excess of 125 colonies). We succeeded in 
isolating the 1.6 kb 5'RACE product. Figure 35 shows the sequence of the full-length 1.6 
kb 5 'RACE product. The sequencing data was analysed by homology searches on databases 
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on both the amino acid level and the DNA level. The sequencing results showed the presence 
of putative exons 2 and 3, and 5' to exon 2 was an open reading frame (out of frame with 
the exon 2/exon 3 reading frame) which has no similarity to exon 1 of the human type I 
GnRHR, or to any other receptor or protein. However, there was a stop codon between this 
frame and the putative exon 2. The sequences 5' to exon 2 may be part of an intron, or 
possibly a PCR artifact. 
The function of this 1.6 kb cDNA fragment is currently unknown. Whether a functional type 
II human GnRHR protein is expressed, is not known at this stage. It is possible that a 
functional protein containing only putative exons 2 and 3 is expressed in human testes. 
Preliminary investigation to test this possibility, by expressing the cDNA in COS-I cells, 
indicate that the exon 2/exon 3 product (i.e. from TM 4 to TM 7) is not functional (J. 
Hapgood, personal communication). 
The failure to isolate an exon I-containing type II GnRHR cDNA by 5'RACE, might be due 
to a very low abundance of the type II GnRHR transcript. This is supported by the very weak 
signals obtained in the PCR reactions using primers 10417 + 10070 to generate the minor -
200 bp band of intron-less RNA (see Figure 25). It is possible that an exon 1 containing 
transcript is expressed in tissues other than those we have examined. It might be expressed 
in a small population of cells at distinct times in development. In this case it would be 
extremely difficult to detect. The 3.5 kb 5'RACE product identified in our Southern (see 
Figure 33) in five tissues and one cell line (testes, fetal brain, thyroid, placenta, daudi, and 
lymphnode) may be the full-length exon I-containing product. Unfortunately we were unable 
to clone this DNA, most likely due to its extremely low abundance. 
We used an alternative genomic DNA approach to attempt to isolate putative exon 1 of the 
type II human GnRHR. P 1 genomic clones containing the putative exon 2 and exon 3 human 
type II GnRHR sequences were purchased from Clonetech. The presence of putative exons 
2 and 3 of the human type II GnRHR in these genomic clones was confirmed by Southern 
blotting (Section 5, Results). Although PCR was performed with different combinations of 
degenerate primers designed to human type I GnRHR sequences that were highly conserved 
between different mammals, we found no indication of the presence of a putative exon 1. 
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Our inability to obtain any indication of exon I-like sequences could be due to the absence 
of exon 1 in our genomic clones. However, since the clones contain inserts of 70 kb, we 
would expect exon 1 to be present. Another possibility is that exon 1 of the type II GnRHR 
differs so much from that of the human type I GnRHR, that PCR with degenerate primers did 
not amplify exon 1. One other possibility is that the human type II GnRHR does not contain 
any exon I-like sequence, but that is very unlikely, since the putative exon2/exon3 sequence 
is so similar to that of the human type I GnRHR. It is interesting to note that my colleagues 
working on the type II GnRHR have also not been successful in isolating a putative exon 1 
from toad (Xenopus) cDNA using a similar strategy of 5' RACE (Brigitte Troskie, personal 
communication). 
The type II GnRHR sequence isolated is 67% homologous to the human type I GnRHR, with 
the greatest homology in the carboxyl terminal halves of IC 3, TM 6 and TM 7. The most 
notable feature of the human type II GnRHR is the presence of an intracellular C-terminal tail, 
which is absent in all of the mammalian type I GnRHRs, but present in all other G-protein 
coupled receptors (GPCRs) (Millar et al., 1993, Stojilkovic et al., 1994). Another interesting 
feature of the human type II GnRHR is the uncharacteristically long IC3. The human type 
II GnRHR IC3 is 5 amino acids longer than that of the human type I GnRHR. The 
significance of the long I C3 is not known. 
Whether this type II human GnRHR is actually ever expressed as a functional protein, and in 
which tissues, is not known at this stage. It may be that the type II receptor is the receptor 
for the CII GnRH ligand in humans. If this is the case, then the differences in the amino 
acids of the type I compared to the type II human GnRHR would be likely to confer 
specificity for the mGnRH and CII GnRH ligands, respectively. Further investigations are 
necessary to answer these important questions. 
4.4 Perspectives on PCR as a tool 
In this thesis, PCR has been extensively exploited to investigate several issues, under a variety 
of different applications. Degenerate PCR primers have been used to amplify GnRHRs from 
genomic DNA (gDNA) of different species. In some instances cDNA has been used as 
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template. Gene specific primers (GSPs) have also been exploited to amplify specific cDNAs 
from total cDNA, and to amplify selected regions from genomic clones. A primer designed 
across an exon-exon boundary (in other words, spanning an intron) was used to selectively 
amplify "processed" intron-less GnRHR cDNA from total cDNA. It is thus possible to 
change PCR primers to suit the specificity (GSP vs degenerate primers) of your reactions, as 
well as changing the conditions. Another use of PCR in this thesis was to verify cloned 
inserts directly from colonies, without having to do plasmid preparations. Not only is it much 
less time-consuming than traditional analysing methods, such as plasmid preparations and 
restriction enzyme digestions, but it is also more convenient and inexpensive. It also enables 
one to screen a much greater amount of colonies at the same time, thus in the end permitting 
one to analyze more colonies than with traditional analysis methods. 
In all the PCR applications, reactions were always optimized by choosing the appropriate 
conditions, such as annealing temperature, ionic strength, divalent cation, primer 
concentration, type of enzyme, and cycling conditions. Where necessary, such as in the 
5'RACE reactions, hotstarts were achieved by using Taq antibody. The results of this thesis 
clearly show that by careful choice of primers and optimal conditions, PCR can be an 
invaluable tool. 
One of the major drawbacks of PCR is also illustrated in this thesis. The ability of the 
Polymerase Chain Reaction (PCR) to amplify a single molecule means that trace amounts of 
DNA contaminants, especially plasmids and PCR products which contain many copies of the 
same DNA molecule, could serve as templates, resulting in amplification of the wrong 
template (false positives). In order to minimize any contamination, various precautions were 
taken when performing PCR (see section 12, Materials and Methods). However, despite all 
these precautions, I still had some contamination (see section 2, Results). Since PCR has the 
ability to amplify minute amounts of template, contamination is always a potential problem 
when performing PCR, especially when there is more than one person in a laboratory working 
on the same strategy. It is therefore absolutely critical to include control reactions in all PCR 
reactions performed, and also to confirm any possible positive results obtained. 
The GnRHR has been cloned in a variety of mammalian species, including human (Chi et 
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al., 1993; Kakar et al., 1992), mouse (Reinhart et al., 1992), rat (Eidne et al. , 1992; Kaiser 
et al. , 1992), cattle (Kakar et al., 1993 ), pig (Weesner and Matteri, 1994 ), and sheep (Brooks 
et al. , 1993; Illing et al. , 1993). The first GnRHR to be cloned was the mouse GnRHR, using 
a method based on transfection of cDNAs into cells and screening for GnRH ligand binding. 
Subsequently, the other receptors were all cloned by cDNA library screening, probing with 
cDNAs of mouse GnRHR or other previously identified GnRHRs. From 1994, by which time 
most of the interesting mammalian GnRHRs had been cloned, until 1997, there had been no 
reports in the literature of non-mammalian GnRHRs having been cloned. This is most likely 
due to the low degree of homology at the nucleic acid level between mammalian and non-
























1 - TMl- 50 
MANNA ... SLEQDPNHCSAINNSIPLIQGKLPTLTVSGK IRVTVTFFLFL 
MSDNT . .. SL .... PSVSNASLLPPLTDWRAPSFTPAAQ ARVAATMVLFL 
MAVNQTQRSLVISDNNASATGNADPWTE . . . PTFTLAAK VRVGVTCCFFL 
........... EGDTNTSATHCLEHWVE . .. PRFTKAAK VRVAITA.LLL 
........ . . ................. ......... . GK IRVTATFFLFL 
MANSA . .. SPEQDPNHCSAINNSIPLMQGNLPTLTLSGK IRVTVTFFLFL 
51----- ICl TM2 -- 100 
LSTAFNASFLLKL QKWTQKRKKGKKLSRIK VLLKHLTLANLLETLIVMPL 
FAAVSNLALLISV S .... RGRGRRLASHLR PLIISLVSADLMMTFIVMPL 
IASCSNVAVLCSI GK ........ RSKSHLR VLILSLSVADLLVTFLVMPL 
LAACSNTAVLGSL LRN ....... RRKCAVR PLILSLALADLLVTVAVMPL 
LSTTFNASFLLKL QKWTQKKEKGKKLSRMK VLLKHLTLGNLLETLIVMPL 
LSATFNASFLLKL QKWTQKKEKGKKLSRMK LLLKHLTLANLLETLIVMPL 
101 ECl TM3 IC2 150 
DMV WNVAVQWYAGDGLCK LLCFLKLFAMQTSAFILVVISL DRHHAILHPL 
DAL WNVMVQWYAGELSCK VLNFGKLFAMYSAALVLVVISL DRHWAILYPL 
DVA WNVTVQWYGGDLSGK LLNFLKLFAMTAAALVLVVISL DRHAAVLQPF 
DGM WNITV . .. . ... . .. ................ . .. ... ......... . 
DGM WNITVQWYAGELLCK VLSYLKLFSMYAPAFMMVVISL DRSLAITRPL 
-
Figure 45 Amino acid alignment of GnRHRs cloned from various different 
species. Conserved amino acids are printed in bold. Transmembrane (TM) helices 













































.... . . AGPVPFTQCV 
YLADGSGPT . VFSQCV 
KVKSVD . .... FTQCV 
TAPGVN ..... FTQCA 
AR .. ARRRNGL LLRAAWLGSVLLASPQV . .... . 
ALKSNSKVGQS MVGLAWILSSVFAGPQLYIFRMI HLADSSGQTKVFSQCV 









EIGKQM .. . KH 
THCSFSQWWHQAFYN FFTFSCLFIIPLFIMLICNAKIIF TLTRVLHQDPH 
~ 
251 IC3 TM6 300 
. . ... EIDLNQSSN.NIPRARMRT 
HAPAGEFALPRSFD.NCPRVRLRA 
.. . .. KLQLNQSKN.NIPRARLRT 
. . ... GESLRRSGTDMIPKARKMT 







LKMTIVIVASFIICWTPYYLLGL W .. 




FSPTMLTE . . VPPSLSH 
FDPEMLNR . . VSEPVNH 
FQPEMLKV . . TPEYIHH 
FQPEMINQ . . TPEYLNH 















FDPEMLNR . . LSDPVNH FFFLFAFLNPCFDPLIYGYF SL* ..... . ... . 
351 400 
. . ...... ARAL* ............................. .. . . ... . 
DSSSKEGSGRMLQEEIHAFRQLEVQKTVTSRRAGETKGIGITSI. 
.. ...... . PALSRKEKNSKQLAGSD* .......... . .... ...... . . 
. . .... RVSTLLSRKEKNSKQLAGSD* ... . . . . .. . ............ . 
GIEAAISQHVRHKPISVSEKTTKDGDVNGQVTS . .. GGSN . GTTVNTVC* 
Figure 45 ( continued) Amino acid alignment of GnRHRs cloned from various 
different species. Conserved amino acids are printed in bold. Transmembrane 
(TM) helices are indicated with boxes. Extracellular (EC) and intracellular (IC) 
loops are also marked. The position of the exon 2/exon 3 boundary determined 




to the PCR strategy, but based on screening of cDNA libraries with mammalian GnRHR 
cDNAs, had been unsuccessful. The PCR strategy using degenerate primers to regions of the 
mammalian GnRHR which were predicted to be conserved, presented a new approach. 
Looking at Figure 45 it is quite obvious that there is considerable homology between these 
GnRHRs from different species. There is a notably higher conservation of sequence in the 
transmembrane helices, as opposed to the intracellular and extracellular loops, as one would 
expect. Another interesting observation, is that the non-mammalian GnRHRs differ in length 
and sequence in the loops quite strikingly from the mammalian GnRHRs. 
It is clear that the success of this PCR strategy lies in the occurrence of at least some highly 
conserved regions in the GnRHRs, and the fortuitous choice of degenerate primers being used 
to these regions. In additions, these conserved regions probably need to contain codons of 
low degeneracy to enable the correct primers to anneal specifically in the presence of an 
excess of non-specific primers in the degenerate mix of primers. This is evident from the lack 
of success of some of the degenerate primers in amplifying the mole GnRHR (see section 
3, Results). Despite a predicted high degree of conservation of the full-length GnRHR of the 
mole compared to other mammalian GnRHRs, as shown by the results with exon 1, only one 
pair of the PCR degenerate primers was successful in amplifying the mole GnRHR from 
gDNA. Similar results were obtained with the non-mammalian GnRHRs from toad (Brigitte 
Troskie, personal communication) and chicken (Yuh-man Sun, personal communication), 
although in this case the lack of success of most of the primers may have been due to a lack 
of conservation of sequence within the transmembrane domains. Thus, while the PCR 
strategy with degenerate primers is a powerful tool in obtaining GnRHR DNA sequences from 
different species, its success is by no means guaranteed, even if the full-length receptor, or 
regions of the receptors are highly conserved with the sequence to which the primers are 
designed. 
APPENDIX A 
LIST OF OLIGO'S USED FOR PCR 
JH1S: 
23 mer 





5' CTC GAA TTC GAT GGN ATG TGG AAC ATA AC 3' 




























5' ACA CTC GAG GG ATC AAA ACA NGG GTT 3' 
G G G A 
JH6A2: 
26 mer 
5' ACA CTC GAG CC ATA GAT NTG NGG ATC 3 I 








5' AA NGC GTG TAT TTC TTC TTG 3' 




5' ACT CAC TAT AGG GCT CGA GCG GC 3' 
APl: 
27 mer 









5' CUA CUA CUA CUA GGC CAC GCG TCG ACT AGT AC 3' 
JHE1S3: 
17 mer 
5' GCA GGA CCA ATT TAC TG 3' 
JHE1A2: 
20 mer 
5' GGG TTA ACA ATC TGA CTT GC 3' 
JHE1S: 
22 mer 
5' GAA AGC ACC TGA GTC ATT GGA G 3' 
JHElA: 
22 mer 
5' CTC CAA TGA CTC AGG TGC TTT C 3' 
JHE2E3A: 
25 mer 
5' AAA TTC ACC AGC AGG GGC ATG GCT C 3' 
JHE2E3S: 
27 mer 
5' CAA GGA AGG GGA GCC ATG CCC CTG CTG 3' 
JHE2: 
24 mer 
5' CCT TGA AGC TGC CTT TGG TGA CAC 3' 
10242: 
20 mer 
5' GGT TAT AGG TGG TCT CTT GC 3' 
10417: 
21 mer 
5' GCA AGA GAC CAC CTA TAA CCT 3' 
10063: 
26 mer 
5' CTG ACC TTC ATC CTC TGC TGG ACG CC 3' 
10068: 
27 mer 
5' GAG CAT TTC TCC CAG ACC CTT CTT TAG 3' 
10351: 
23 mer 
5' GGT GTC CCC GTG TTC GTC TCC GG 3' 
10350: 
23 mer 
5' GGC CGG AGA CGA ACA CGG GGA CA 3' 
10070: 
26 mer 




5' GGA GAG CAG GAG TAG AAG TGA G 3' 
10349: 
25 mer 
5' GGA ACC TCT TCA CCT TCT GCT GCC T 3' 
10069: 
27 mer 
5' CTA AAG AAG GGT CTG GGA GAA ATG CTC 3' 
JHi2S: 
30 mer 
5' CCT TAA TCC TTA ACC CTA GAA CCT GTT GCC 3' 
JHi2A: 
30 mer 
5' GAC ACT CAG TCT TCT GAT CTG AGT ATA GGG 3' 
T7 PROMOTER PRIMER: 
20 mer 
5' ATT ATG CTG AGT GAT ATC CC 3' 
U19MER PRIMER: 
19 mer 
5' GTT TTC CCA GTC ACG ACG T 3' 
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APPENDIX B 
COMMONLY USED MEDIUM 
LB Medium (Luria-Bertani Medium) 
Per liter deionized water, add: 
bacto-tryptone 10 g 
bacto-yeast extract 5 g 
NaCl 10 g 
Sterilize by autoclaving. 
Terrific Broth 
Per liter: 
To 900 ml deionized H20, add: 
bacto-tryptone 12 g 
bacto-yeast extract 24 g 
glycerol 4 ml 
106 
Sterilize by autoclaving. Allow to cool to 60°C, and then add 100 ml of a sterile solution 
of 0.17 M KH2P04, 0.72 M K2HP04• 
SOC Medium 
Per liter: 
bacto-tryptone 20 g 
bacto-yeast extract 5 g 
NaCl 0.5 g 
Add 10 mol of a 250 mM solution of KCL Adjust pH to 7.0 with 5 N NaOH. Adjust 
volume to 1 liter, and sterilize by autoclaving. Just before use add 5 ml of a sterile 
solution of 2 M MgC12, and 20 ml of a sterile IM solution of glucose. 
2 x YT Medium 
Per liter: 
bacto-tryptone 16 g 
bacto-yeast extract 10 g 
NaCl 5 g 
Sterilize by autoclaving. 
APPENDIX C 
PLASMID MAP OF pMOSBlue T-VECTOR 
lacZ srart 
Sao 1(2M3l , 
\ 
Atl ll k2$o'61 
~lwN 1121J7'1 ~ 
Hq1E 11(196<! /" . 
\ 
\ 
T7 promocer primer 
T7 promoter 
Sail 
Sse8387 I Hine II 
Hind III Sph I Pst I Ace l Xba I Spe l 
ATGACCATGATTACGCCAAGCTCTAATACCACTCACTATAGGGAAAGCTTGCATGCCTGCAGGTCGACTCTAGAGGATCTACTAGT 
SmaI 
Ava I Ban II 




! T-vecror cloning 
accggac .. . 
Tcagccra .. . 
U- l 9mer primer 
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